Babcock & Wilcox Q3 2026 revenue rises to $291M

The board authorized a share repurchase program of up to $50 million, with no obligation to purchase shares.

Available on EDGAR 11/09/2026 - 04:30 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:29 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Babcock & Wilcox Enterprises, Inc. (BW) reported third-quarter 2026 revenue of $290.8 million, compared with $139.2 million a year earlier, as higher large-project volume included $77.8 million from Base Electron. Operating income was $13.8 million versus $3.4 million. Income from continuing operations was $93.5 million, compared with a $6.2 million loss, including $85.1 million of income from a change in fair value of customer warrants.

For the nine months ended September 30, 2026, revenue was $824.9 million versus $426.7 million, while net cash used in operating activities was $130.3 million versus $65.9 million. Cash, cash equivalents and restricted cash totaled $128.9 million at September 30, 2026. The company reported $2.5 billion of remaining performance obligations and a $2.4 billion Base Electron contract to design and install four 300-megawatt natural gas-fired power plants, targeted to begin commercial operation in 2030. It expects to recognize approximately 10% of backlog in 2026, 28% in 2027 and 62% thereafter. Under its share repurchase program, it repurchased 3.9 million shares for $37.9 million during the nine-month period, including 1.3 million shares from its pension trust.

2 points · 0 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 1 point

How the balance works

Positive

• Moderate pointQuarterly revenue reached $290.8 million, versus $139.2 million a year earlier.
• Moderate pointContinuing-operations income was $93.5 million, versus a $6.2 million loss.

Negative

• Moderate pointOperating cash use was $130.3 million for nine months, versus $65.9 million.

Filing Explained

The completed share sales expanded B&W’s common share base; the fully vested Base Electron warrant could add shares if exercised.

The 10-Q reports completed common-stock sales: 4.4 million shares under the at-the-market agreement for $41.9 million net, and 12.4 million shares in the public offering completed on May 18, 2026, for $218.2 million net.

Those issuer sales added shares to the common share base, reducing existing holders’ percentage ownership absent offsetting changes. The filing reports 145.446 million common shares outstanding at September 30, 2026.

The Base Electron arrangements also include an issued initial warrant exercisable for 2.6 million shares and an additional warrant for up to 7.86 million shares; the additional warrant became fully vested when the Base Electron agreement was signed. If exercised into shares, the warrants would add shares and reduce existing holders’ percentage ownership absent offsetting changes.

Key Figures

Revenue: $290.8 million Operating income: $13.8 million Income from continuing operations: $93.5 million +5 more

8 metrics

Revenue $290.8 million Three months ended September 30, 2026; compared with $139.2 million in 2025

Operating income $13.8 million Three months ended September 30, 2026; compared with $3.4 million in 2025

Income from continuing operations $93.5 million Three months ended September 30, 2026; compared with a $6.2 million loss in 2025

Change in fair value of customer warrants $85.1 million of income Three months ended September 30, 2026

Revenue $824.9 million Nine months ended September 30, 2026; compared with $426.7 million in 2025

Net cash used in operating activities $130.3 million Nine months ended September 30, 2026; compared with $65.9 million in 2025

Base Electron contract consideration $2.4 billion Agreement for the design and installation of four 300-megawatt natural gas-fired power plants

Remaining performance obligations $2.5 billion As of September 30, 2026; also referred to as total backlog

Key Terms

remaining performance obligations, asset-based Credit Facility, at-the-market offering, Level 3, +1 more

5 terms

remaining performance obligations financial

"remaining performance obligations, which we also refer to as total backlog"

Remaining performance obligations are the work a company still needs to complete for its customers, like finishing a service or delivering a product. It’s important because it shows how much future income the company has coming in from current agreements, giving a clearer picture of its ongoing business.

asset-based Credit Facility financial

"up to $150.0 million asset-based Credit Facility"

A credit line that a lender extends to a company using the company’s tangible assets — such as accounts receivable, inventory, or equipment — as collateral; the amount the company can borrow rises and falls with the value of those assets. Think of it like a business version of a home equity line where unpaid invoices or stock on shelves serve as the lender’s security. Investors care because it affects a company’s ability to meet short-term obligations and grow: availability can signal healthy cash flow, while heavy reliance or tight terms can indicate financial strain and raise the risk that lenders could seize pledged assets.

at-the-market offering financial

"in connection with an at-the-market offering"

An at-the-market offering is a method companies use to sell new shares of stock directly into the open market over time, rather than all at once. This allows them to raise money gradually, similar to selling small pieces of a product instead of a large batch. For investors, it means the company can access funding more flexibly, but it may also increase the supply of shares and influence the stock’s price.

Level 3 financial

"categorized within Level 3 of the fair value hierarchy"

Level 3 describes the lowest-confidence category in the accounting “fair value” hierarchy, covering assets or liabilities whose prices are not observable in the market and must be estimated using judgment and internal models. For investors, Level 3 items matter because they can introduce greater uncertainty and potential valuation swings—like valuing a unique antique versus checking a price tag on a supermarket shelf—so they signal higher model risk and lower liquidity.

fixed charge coverage test financial

"including a quarterly fixed charge coverage test"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did BW report in Q3 2026?

B&W reported $290.8 million of revenue for the three months ended September 30, 2026, compared with $139.2 million in the prior-year quarter. Management said the increase primarily reflected higher large-project volume, including $77.8 million from Base Electron.

What is BW's Base Electron contract worth and what does it cover?

The contract provides $2.4 billion in total consideration for the design and installation of four 300-megawatt natural gas-fired power plants. It includes $2.0 billion of variable charges based on reimbursable costs plus a markup, with the balance as a fixed fee. Commercial operation is targeted for 2030.

What are the terms of BW's share repurchase program?

The board authorized a program of up to $50 million. The company may repurchase shares from time to time in open-market or privately negotiated transactions, block trades, or under trading plans established in accordance with Rule 10b5-1 or Rule 10b-18. The program does not obligate purchases, has no fixed expiration date, and may be suspended or discontinued.

AI-generated analysis. How Rhea-AI works. Not financial advice.

10-Q Quarterly Reports: What Changes Quarter to Quarter →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

false2026Q3000163080512/3131nominalxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesbw:segmentiso4217:DKKxbrli:purebw:power_plantutr:MWbw:year00016308052026-01-012026-09-300001630805us-gaap:CommonStockMember2026-01-012026-09-300001630805us-gaap:SeriesAPreferredStockMember2026-01-012026-09-3000016308052026-11-0300016308052026-07-012026-09-3000016308052025-07-012025-09-3000016308052025-01-012025-09-3000016308052026-09-3000016308052025-12-310001630805us-gaap:CommonStockMember2025-12-310001630805us-gaap:PreferredStockMember2025-12-310001630805us-gaap:AdditionalPaidInCapitalMember2025-12-310001630805us-gaap:TreasuryStockCommonMember2025-12-310001630805us-gaap:RetainedEarningsMember2025-12-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001630805us-gaap:RetainedEarningsMember2026-01-012026-03-3100016308052026-01-012026-03-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001630805us-gaap:CommonStockMember2026-01-012026-03-310001630805us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001630805us-gaap:TreasuryStockCommonMember2026-01-012026-03-310001630805us-gaap:CommonStockMember2026-03-310001630805us-gaap:PreferredStockMember2026-03-310001630805us-gaap:AdditionalPaidInCapitalMember2026-03-310001630805us-gaap:TreasuryStockCommonMember2026-03-310001630805us-gaap:RetainedEarningsMember2026-03-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-3100016308052026-03-310001630805us-gaap:RetainedEarningsMember2026-04-012026-06-3000016308052026-04-012026-06-300001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300001630805us-gaap:CommonStockMember2026-04-012026-06-300001630805us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300001630805us-gaap:TreasuryStockCommonMember2026-04-012026-06-300001630805us-gaap:CommonStockMember2026-06-300001630805us-gaap:PreferredStockMember2026-06-300001630805us-gaap:AdditionalPaidInCapitalMember2026-06-300001630805us-gaap:TreasuryStockCommonMember2026-06-300001630805us-gaap:RetainedEarningsMember2026-06-300001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-3000016308052026-06-300001630805us-gaap:RetainedEarningsMember2026-07-012026-09-300001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-300001630805us-gaap:CommonStockMember2026-07-012026-09-300001630805us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300001630805us-gaap:TreasuryStockCommonMember2026-07-012026-09-300001630805us-gaap:CommonStockMember2026-09-300001630805us-gaap:PreferredStockMember2026-09-300001630805us-gaap:AdditionalPaidInCapitalMember2026-09-300001630805us-gaap:TreasuryStockCommonMember2026-09-300001630805us-gaap:RetainedEarningsMember2026-09-300001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-09-300001630805us-gaap:CommonStockMember2024-12-310001630805us-gaap:PreferredStockMember2024-12-310001630805us-gaap:AdditionalPaidInCapitalMember2024-12-310001630805us-gaap:TreasuryStockCommonMember2024-12-310001630805us-gaap:RetainedEarningsMember2024-12-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001630805us-gaap:NoncontrollingInterestMember2024-12-3100016308052024-12-310001630805us-gaap:RetainedEarningsMember2025-01-012025-03-310001630805us-gaap:NoncontrollingInterestMember2025-01-012025-03-3100016308052025-01-012025-03-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001630805us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001630805us-gaap:CommonStockMember2025-01-012025-03-310001630805us-gaap:CommonStockMember2025-03-310001630805us-gaap:PreferredStockMember2025-03-310001630805us-gaap:AdditionalPaidInCapitalMember2025-03-310001630805us-gaap:TreasuryStockCommonMember2025-03-310001630805us-gaap:RetainedEarningsMember2025-03-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001630805us-gaap:NoncontrollingInterestMember2025-03-3100016308052025-03-310001630805us-gaap:RetainedEarningsMember2025-04-012025-06-300001630805us-gaap:NoncontrollingInterestMember2025-04-012025-06-3000016308052025-04-012025-06-300001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300001630805us-gaap:CommonStockMember2025-04-012025-06-300001630805us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300001630805us-gaap:CommonStockMember2025-06-300001630805us-gaap:PreferredStockMember2025-06-300001630805us-gaap:AdditionalPaidInCapitalMember2025-06-300001630805us-gaap:TreasuryStockCommonMember2025-06-300001630805us-gaap:RetainedEarningsMember2025-06-300001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001630805us-gaap:NoncontrollingInterestMember2025-06-3000016308052025-06-300001630805us-gaap:RetainedEarningsMember2025-07-012025-09-300001630805us-gaap:NoncontrollingInterestMember2025-07-012025-09-300001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300001630805us-gaap:CommonStockMember2025-07-012025-09-300001630805us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001630805us-gaap:TreasuryStockCommonMember2025-07-012025-09-300001630805us-gaap:CommonStockMember2025-09-300001630805us-gaap:PreferredStockMember2025-09-300001630805us-gaap:AdditionalPaidInCapitalMember2025-09-300001630805us-gaap:TreasuryStockCommonMember2025-09-300001630805us-gaap:RetainedEarningsMember2025-09-300001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001630805us-gaap:NoncontrollingInterestMember2025-09-3000016308052025-09-300001630805bw:VlundMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-04-300001630805bw:VlundMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-04-012025-04-300001630805us-gaap:RelatedPartyMember2025-04-300001630805bw:VlundMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-01-012025-09-300001630805bw:VlundMemberus-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-300001630805bw:DiamondPowerMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-06-300001630805bw:DiamondPowerMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-06-012025-06-300001630805bw:DiamondPowerMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-07-012025-09-300001630805bw:DiamondPowerMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-01-012025-09-300001630805bw:DiamondPowerMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-07-012026-09-300001630805bw:DiamondPowerMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-01-012026-09-300001630805bw:AllenShermanHoffLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-10-012025-10-310001630805bw:AllenShermanHoffLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-10-012025-12-310001630805bw:BabcockWilcoxRenewableServiceASBWRSMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2024-01-012024-12-310001630805bw:BabcockWilcoxRenewableServiceASBWRSMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-01-012025-03-310001630805bw:BabcockWilcoxRenewableServiceASBWRSMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-01-012026-03-310001630805bw:BWSolarMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-07-012025-09-300001630805bw:VlundMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-07-012025-09-300001630805bw:DiamondPowerMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-07-012025-09-300001630805bw:AllenShermanHoffLLCMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-07-012025-09-300001630805us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-07-012025-09-300001630805bw:BWSolarMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-01-012025-09-300001630805bw:BabcockWilcoxRenewableServiceASBWRSMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-01-012025-09-300001630805bw:VlundMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-01-012025-09-300001630805bw:DiamondPowerMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-01-012025-09-300001630805bw:AllenShermanHoffLLCMemberus-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-01-012025-09-300001630805us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember2025-01-012025-09-300001630805bw:BWMemberbw:PartsMember2026-07-012026-09-300001630805bw:BWMemberbw:PartsMember2025-07-012025-09-300001630805bw:BWMemberbw:PartsMember2026-01-012026-09-300001630805bw:BWMemberbw:PartsMember2025-01-012025-09-300001630805bw:BWMemberbw:ProjectsMember2026-07-012026-09-300001630805bw:BWMemberbw:ProjectsMember2025-07-012025-09-300001630805bw:BWMemberbw:ProjectsMember2026-01-012026-09-300001630805bw:BWMemberbw:ProjectsMember2025-01-012025-09-300001630805bw:BWMemberus-gaap:ConstructionMember2026-07-012026-09-300001630805bw:BWMemberus-gaap:ConstructionMember2025-07-012025-09-300001630805bw:BWMemberus-gaap:ConstructionMember2026-01-012026-09-300001630805bw:BWMemberus-gaap:ConstructionMember2025-01-012025-09-300001630805bw:BWMember2026-07-012026-09-300001630805bw:BWMember2025-07-012025-09-300001630805bw:BWMember2026-01-012026-09-300001630805bw:BWMember2025-01-012025-09-300001630805us-gaap:TransferredOverTimeMember2026-01-012026-09-300001630805us-gaap:TransferredOverTimeMember2026-07-012026-09-300001630805us-gaap:TransferredOverTimeMember2025-01-012025-09-300001630805us-gaap:TransferredOverTimeMember2025-07-012025-09-300001630805us-gaap:TransferredAtPointInTimeMember2025-01-012025-09-300001630805us-gaap:TransferredAtPointInTimeMember2026-07-012026-09-300001630805us-gaap:TransferredAtPointInTimeMember2026-01-012026-09-300001630805us-gaap:TransferredAtPointInTimeMember2025-07-012025-09-300001630805bw:AppliedDigitalBaseElectronMember2026-02-260001630805bw:AppliedDigitalBaseElectronMember2026-02-262026-02-260001630805bw:AppliedDigitalBaseElectronMember2026-07-012026-09-300001630805bw:AppliedDigitalBaseElectronMember2026-01-012026-09-300001630805bw:AppliedDigitalBaseElectronMember2026-09-300001630805us-gaap:SegmentContinuingOperationsMember2025-01-012025-09-3000016308052026-10-012026-09-3000016308052027-01-012026-09-3000016308052028-01-012026-09-300001630805us-gaap:LandMember2026-09-300001630805us-gaap:LandMember2025-12-310001630805us-gaap:BuildingMember2026-09-300001630805us-gaap:BuildingMember2025-12-310001630805us-gaap:MachineryAndEquipmentMember2026-09-300001630805us-gaap:MachineryAndEquipmentMember2025-12-310001630805us-gaap:ConstructionInProgressMember2026-09-300001630805us-gaap:ConstructionInProgressMember2025-12-310001630805us-gaap:CustomerRelationshipsMember2026-09-300001630805us-gaap:CustomerRelationshipsMember2025-12-310001630805us-gaap:UnpatentedTechnologyMember2026-09-300001630805us-gaap:UnpatentedTechnologyMember2025-12-310001630805us-gaap:PatentedTechnologyMember2026-09-300001630805us-gaap:PatentedTechnologyMember2025-12-310001630805us-gaap:TradeNamesMember2026-09-300001630805us-gaap:TradeNamesMember2025-12-310001630805us-gaap:OtherIntangibleAssetsMember2026-09-300001630805us-gaap:OtherIntangibleAssetsMember2025-12-3100016308052025-01-012025-12-310001630805us-gaap:PensionPlansDefinedBenefitMember2026-07-012026-09-300001630805us-gaap:PensionPlansDefinedBenefitMember2025-07-012025-09-300001630805us-gaap:PensionPlansDefinedBenefitMember2026-01-012026-09-300001630805us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-09-300001630805us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2026-07-012026-09-300001630805us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-07-012025-09-300001630805us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2026-01-012026-09-300001630805us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes650Due2026Member2026-01-012026-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes650Due2026Member2026-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes650Due2026Member2025-12-310001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8.75Due2030Member2026-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8.75Due2030Member2025-12-310001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8.75Due2030Member2025-05-310001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8125Due2026Member2025-05-310001630805us-gaap:SeniorNotesMemberbw:SeniorNotes650Due2026Member2025-05-310001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8.75Due2030Member2025-05-312025-05-310001630805us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberbw:CreditFacilityMember2024-01-310001630805us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMember2024-01-310001630805bw:DebtInstrumentCovenantOneMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMemberbw:CreditFacilityMember2024-01-012024-01-310001630805bw:DebtInstrumentCovenantOneMemberus-gaap:RevolvingCreditFacilityMemberbw:CreditFacilityMember2024-01-310001630805bw:DebtInstrumentCovenantTwoMemberus-gaap:SecuredOvernightFinancingRateSofrMemberbw:CreditFacilityMember2024-01-012024-01-310001630805bw:DebtInstrumentCovenantTwoMemberus-gaap:RevolvingCreditFacilityMemberbw:CreditFacilityMember2024-01-310001630805us-gaap:RevolvingCreditFacilityMemberus-gaap:FederalFundsEffectiveSwapRateMemberbw:CreditFacilityMember2024-01-012024-01-310001630805us-gaap:RevolvingCreditFacilityMemberbw:DailySimpleSecuredOvernightFinancingRateSOFRMemberbw:CreditFacilityMember2024-01-012024-01-310001630805us-gaap:RevolvingCreditFacilityMemberbw:CreditFacilityMember2024-01-012024-01-310001630805us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberbw:CreditFacilityMember2024-01-012024-01-310001630805us-gaap:RevolvingCreditFacilityMemberbw:CreditFacilityMember2024-01-310001630805us-gaap:RevolvingCreditFacilityMemberbw:CreditFacilityMember2026-02-250001630805us-gaap:LineOfCreditMemberbw:CreditFacilityMember2026-09-300001630805bw:CreditFacilityMember2026-09-300001630805bw:PerformanceLettersOfCreditMember2026-09-300001630805bw:PerformanceLettersOfCreditMember2025-12-310001630805bw:FinancialLettersOfCreditMember2026-09-300001630805bw:FinancialLettersOfCreditMember2025-12-310001630805bw:BackstoppedBondsMember2026-09-300001630805bw:BackstoppedBondsMember2025-12-310001630805us-gaap:SuretyBondMember2026-09-300001630805us-gaap:SuretyBondMember2025-12-310001630805bw:LettersOfCreditSubjectToForeignCurrencyRevaluationMember2026-09-300001630805bw:LettersOfCreditSubjectToForeignCurrencyRevaluationMember2025-12-310001630805bw:LetterOfCreditNonDomesticFacilitiesMember2026-09-300001630805bw:LetterOfCreditNonDomesticFacilitiesMember2025-12-310001630805bw:SaleLeasebackFinancingTransactionsMember2026-09-300001630805bw:SaleLeasebackFinancingTransactionsMember2025-12-310001630805bw:StateOfWestVirginiaMemberbw:ForgivableLoanMember2026-09-300001630805bw:StateOfWestVirginiaMemberbw:ForgivableLoanMember2025-12-310001630805us-gaap:RevolvingCreditFacilityMember2026-07-012026-09-300001630805us-gaap:RevolvingCreditFacilityMember2025-07-012025-09-300001630805us-gaap:RevolvingCreditFacilityMember2026-01-012026-09-300001630805us-gaap:RevolvingCreditFacilityMember2025-01-012025-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes650Due2026Member2026-07-012026-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes650Due2026Member2025-07-012025-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes650Due2026Member2025-01-012025-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8.75Due2030Member2026-07-012026-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8.75Due2030Member2025-07-012025-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8.75Due2030Member2026-01-012026-09-300001630805us-gaap:SeniorNotesMemberbw:SeniorNotes8.75Due2030Member2025-01-012025-09-300001630805us-gaap:SeriesAPreferredStockMember2026-09-300001630805bw:AtTheMarketOfferingMember2025-01-012025-09-300001630805bw:TwoThousandTwentyFiveSalesAgreementMember2025-11-300001630805bw:TwoThousandTwentyFiveSalesAgreementMember2026-01-012026-09-300001630805bw:PublicStockOfferingIncludingOverAllotmentOptionMember2026-05-182026-05-180001630805bw:PublicStockOfferingMember2026-05-182026-05-1800016308052026-05-182026-05-1800016308052026-07-130001630805srt:AffiliatedEntityMember2026-07-012026-09-300001630805bw:AppliedDigitalBaseElectronMember2025-11-300001630805us-gaap:PrivatePlacementMember2025-11-012025-11-300001630805us-gaap:PrivatePlacementMember2025-11-300001630805bw:InitialWarrantsMember2025-11-300001630805bw:AdditionalWarrantsMember2025-11-300001630805bw:WarrantsMember2026-03-180001630805bw:InitialWarrantsMember2026-09-300001630805bw:InitialWarrantsMember2025-12-310001630805bw:AdditionalWarrantsMember2026-09-300001630805bw:WarrantsMember2026-07-012026-09-300001630805bw:WarrantsMember2026-01-012026-09-300001630805us-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-300001630805us-gaap:MeasurementInputRiskFreeInterestRateMember2025-12-310001630805us-gaap:MeasurementInputPriceVolatilityMember2026-09-300001630805us-gaap:MeasurementInputPriceVolatilityMember2025-12-310001630805us-gaap:MeasurementInputExercisePriceMember2026-09-300001630805us-gaap:MeasurementInputExercisePriceMember2025-12-310001630805us-gaap:MeasurementInputExpectedTermMember2026-09-300001630805us-gaap:MeasurementInputExpectedTermMember2025-12-310001630805bw:CashandCashEquivalentsForeignOperationsMember2026-09-300001630805bw:CashandCashEquivalentsForeignOperationsMember2025-12-310001630805country:US2026-09-300001630805country:US2025-12-310001630805bw:CashHeldToMeetReinsuranceReserveRequirementsMember2026-09-300001630805bw:CashHeldToMeetReinsuranceReserveRequirementsMember2025-12-310001630805bw:ProjectIndemnityCollateralMember2026-09-300001630805bw:ProjectIndemnityCollateralMember2025-12-310001630805bw:LettersOfCreditCollateralMember2026-09-300001630805bw:LettersOfCreditCollateralMember2025-12-310001630805bw:EscrowMember2026-09-300001630805bw:EscrowMember2025-12-310001630805srt:MinimumMember2026-05-200001630805srt:MaximumMember2026-05-200001630805us-gaap:RestrictedStockUnitsRSUMember2025-12-310001630805us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-300001630805us-gaap:RestrictedStockUnitsRSUMember2026-09-300001630805us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-09-300001630805bw:RestrictedStockUnitsWithMarketConditionsMember2022-07-012022-07-3100016308052026-03-050001630805bw:RestrictedStockUnitsWithMarketConditionsMember2026-03-052026-03-050001630805bw:RestrictedStockUnitsWithMarketConditionsMember2026-01-012026-09-300001630805bw:RestrictedStockUnitsWithMarketConditionsMember2025-01-012025-09-300001630805us-gaap:StockAppreciationRightsSARSMember2026-09-300001630805us-gaap:StockAppreciationRightsSARSMember2026-07-012026-09-300001630805us-gaap:StockAppreciationRightsSARSMember2026-01-012026-09-300001630805us-gaap:StockAppreciationRightsSARSMember2025-01-012025-12-310001630805us-gaap:StockAppreciationRightsSARSMember2025-12-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-12-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-03-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-01-012026-03-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2026-03-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-03-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2026-04-012026-06-300001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-04-012026-06-300001630805us-gaap:AccumulatedTranslationAdjustmentMember2026-06-300001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-06-300001630805us-gaap:AccumulatedTranslationAdjustmentMember2026-07-012026-09-300001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-07-012026-09-300001630805us-gaap:AccumulatedTranslationAdjustmentMember2026-09-300001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-09-300001630805us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-03-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-03-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-03-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-03-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-04-012025-06-300001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-04-012025-06-300001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-06-300001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-06-300001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-07-012025-09-300001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-07-012025-09-300001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-09-300001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2026-07-012026-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2025-07-012025-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-07-012026-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-07-012025-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-01-012026-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-01-012026-09-300001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300001630805us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Member2026-09-300001630805us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Member2025-12-310001630805us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001630805us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001630805srt:MinimumMember2026-09-300001630805srt:MaximumMember2026-09-300001630805us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2026-09-300001630805bw:B.RileyCapitalManagementLLCMemberbw:BabcockWilcoxEnterprisesInc.Member2026-01-012026-09-300001630805bw:AnnualFeeMemberus-gaap:RevolvingCreditFacilityMemberbw:CreditFacilityMember2024-01-012024-01-310001630805bw:BRileySecuritiesIncMembersrt:AffiliatedEntityMember2025-11-300001630805bw:BRileySecuritiesIncMembersrt:AffiliatedEntityMember2024-04-300001630805bw:BRileySecuritiesIncMembersrt:AffiliatedEntityMember2026-03-310001630805bw:BRileySecuritiesIncMembersrt:AffiliatedEntityMember2026-01-012026-03-310001630805bw:BRileySecuritiesIncMembersrt:AffiliatedEntityMember2026-01-012026-09-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2026

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File No. 001-36876 

BABCOCK & WILCOX ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

Delaware						47-2783641
(State or other Jurisdiction of Incorporation or Organization)						(I.R.S. Employer Identification No.)
1200 East Market Street, Suite 650
Akron, Ohio						44305
(Address of Principal Executive Offices)						(Zip Code)

Registrant's Telephone Number, Including Area Code: (330) 753-4511

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $0.01 par value			BW			New York Stock Exchange
7.75% Series A Cumulative Perpetual Preferred Stock			BW PRA			New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☒

Non-accelerated filer

☐

Smaller reporting company

☒

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes  ☐    No  ☒

The number of shares of the registrant's common stock outstanding at November 3, 2026 was 145,446,002.

1

TABLE OF CONTENTS

						PAGE
Cautionary Statement Concerning Forward-Looking Information						4
PART I - FINANCIAL INFORMATION
Item 1.			Condensed Consolidated Financial Statements			5
			Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)			6
			Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)			7
			Condensed Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025 (Unaudited)			8
			Condensed Consolidated Statements of Stockholders' Equity (Deficit) for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)			9
			Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (Unaudited)			11
			Notes to Condensed Consolidated Financial Statements (Unaudited)			13
Item 2.			Management's Discussion and Analysis of Financial Condition and Results of Operations			35
			Business Overview			35
			Results of Operations – Three and Nine Months Ended September 30, 2026 and 2025			36
			Liquidity and Capital Resources			42
			Critical Accounting Policies and Estimates			43
Item 3.			Quantitative and Qualitative Disclosures about Market Risk			44
Item 4.			Controls and Procedures			44
PART II - OTHER INFORMATION
Item 1.			Legal Proceedings			45
Item 1A.			Risk Factors			45
Item 2.			Unregistered Sales of Equity Securities and Use of Proceeds			45
Item 5.			Other Information			46
Item 6.			Exhibits			46
SIGNATURES						48

2

Definitions

In this Quarterly Report on Form 10-Q, or this "Quarterly Report", unless the context otherwise indicates, "B&W," "we," "us," "our" or the "Company" mean Babcock & Wilcox Enterprises, Inc. and its consolidated subsidiaries. Unless otherwise noted, discussion of our business and results of operations in this Quarterly Report on Form 10-Q refers to our continuing operations.

Abbreviation or acronym						Term
6.50% Senior Notes						6.50% Senior Notes due December 31, 2026 issued by Babcock & Wilcox Enterprises, Inc. in 2021, fully redeemed as of August 31, 2026
8.125% Senior Notes						8.125% Senior Notes due February 28, 2026 issued by Babcock & Wilcox Enterprises, Inc. in 2021, fully redeemed as of December 31, 2025
8.75% Senior Notes						8.75% Senior Secured Notes due June 30, 2030 issued by Babcock & Wilcox Enterprises, Inc. in 2025
Agents						Collectively, B. Riley Securities, Inc., Seaport Global Securities LLC, Craig-Hallum Capital Group LLC and Lake Street Capital Markets, LLC
2025 Agents						Collectively, B. Riley Securities, Inc. and Lake Street Capital Markets, LLC
AI						Artificial intelligence
AOCI						Accumulated Other Comprehensive Income (loss)
Applied Digital						Applied Digital Corporation
ASC						Accounting Standards Codification
ASH						Allen-Sherman-Hoff Division
ASU						Accounting Standards Update
Axos						Axos Bank, an affiliate of Axos Financial, Inc.
Base Electron						Base Electron, Inc.
B&W Solar						Babcock & Wilcox Solar Energy, Inc., formerly known as Fosler Construction Company, Inc.
B. Riley						BRC Group Holdings, Inc. and its affiliates, a related party
BWRS						Babcock & Wilcox Renewable Service A/S
CODM						Chief Operating Decision Maker, who is our Chief Executive Officer
Credit Agreement						Credit Agreement between us, with certain of our subsidiaries as guarantors, the lenders party thereto from time to time and Axos Bank, as administrative agent, swingline lender and letter of credit issuer on January 18, 2024 (as amended from time to time)
Credit Facility						Revolving credit facility
CTA						Currency translation adjustment
Diamond Power						Diamond Power International, LLC
EBITDA						Earnings before interest, taxes, depreciation and amortization
Exchange Act						The Securities Exchange Act of 1934, as amended
FASB						Financial Accounting Standards Board
GAAP						Generally Accepted Accounting Principles in the United States of America
GMAB						Babcock & Wilcox Vølund AB f/k/a Gӧtaverken Miljӧ AB
MTM						Mark-to-Market
NOL						Net operating losses
NYSE						New York Stock Exchange
PBGC						Pension Benefit Guaranty Corporation
Preferred Stock						7.75% Series A Cumulative Perpetual Preferred Stock
Sales Agreement						Sales agreement with B. Riley Securities, Inc., Seaport Global Securities LLC, Craig-Hallum Capital Group LLC and Lake Street Capital Markets, LLC
2025 Sales Agreement						Sales agreement with B. Riley Securities, Inc. and Lake Street Capital Markets, LLC
SEC						United States Securities and Exchange Commission
Securities Act						The Securities Act of 1933, as amended

3

Abbreviation or acronym						Term
Senior Notes Due 2026						Collectively, the 8.125% Senior Notes due February 28, 2026 and the 6.50% Senior Notes due December 31, 2026. The 8.125% Senior Notes were fully redeemed as of December 31, 2025 and the 6.50% Senior Notes were fully redeemed as of August 31, 2026
SG&A						Selling, general and administrative expenses
SOFR						The Secured Overnight Financing Rate
SPIG						SPIG S.p.A

***** Cautionary Statement Concerning Forward-Looking Information *****

This Quarterly Report on Form 10-Q, including Management's Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements other than statements of historical or current fact included in this Quarterly Report are forward-looking statements. You should not place undue reliance on these statements. Forward-looking statements may include words such as "expect," "intend," "plan," "likely," "seek," "believe," "project," "forecast," "target," "goal," "potential," "estimate," "may," "might," "will," "would," "should," "could," "can," "have," "due," "anticipate," "assume," "contemplate," "continue" and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operational performance or other events.

The forward-looking statements included herein are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, or otherwise, except as required by law. These forward-looking statements are based on management's current expectations and involve a number of risks and uncertainties, including, but not limited to: the potential for future conditions that could raise substantial doubt as to our ability to continue as a going concern, which has occurred in the past; risks associated with contractual pricing in our industry; disputes with customers with long-term contracts; the performance of third parties' and subcontractors' on whom we rely; disruptions at our or third-party manufacturing facilities; our ability to execute our growth strategy; our evaluation of strategic alternatives; our ability to deliver our backlog on time or at all; professional liability, product liability, warranty or other claims; inadequate insurance coverage; our ability to compete successfully against current and future competitors; our development of new products; cyclical and economic impacts on demand for our products; compliance with government regulations; legislative and regulatory developments impacting our business; supply chain issues; the financial and other covenants in our debt agreements; our ability to maintain adequate bonding and letter of credit capacity; impairment to our goodwill or other indefinite-lived intangible assets; our exposure to credit risk; disruptions in, or failures of, our information technology systems, including those related to cybersecurity; failure to comply with data and privacy laws, regulations and standards, or if we fail to properly maintain the integrity of our data, protect our proprietary rights to our systems or defend against cybersecurity attacks, we may be subject to government or private actions due to breaches; failure to protect our intellectual property rights, or inability to obtain or renew licenses to use intellectual property of third parties; uncertainty over tariffs and their impacts; sanctions and export controls; international political, economic and other uncertainties; fluctuations in the value of foreign currencies could harm our profitability; volatility of the market price and trading volume of our common stock; dilution of our common shareholders' ownership or voting power; the significant influence of B. Riley over us; anti-takeover provisions in our corporate documents; changes in tax rates or tax law; our ability to use NOL and certain tax credits; failure to maintain effective internal control over financial reporting; new accounting pronouncements or changes in existing accounting standards and practices; our ability to attract and maintain key personnel; our relationship with labor unions; a nationwide shortage of skilled labor; pension and medical expenses associated with our retirement benefit; natural disasters or other events beyond our control; and the risks and uncertainties described under the heading "Risk Factors" in Part I, Item 1A of our Annual Report and in Part II, Item 1A of our Quarterly Reports on Form 10-Q, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with the SEC.

These forward-looking statements are made based upon detailed assumptions and reflect management's current expectations and beliefs. While we believe that these assumptions underlying the forward-looking statements are reasonable, forward-looking statements are subject to uncertainties and factors relating to our operations and business environment that are difficult to predict and may be beyond our control. Such uncertainties and factors may cause actual results to differ materially from those expressed or implied by the forward-looking statements.

4

PART I

ITEM 1. Condensed Consolidated Financial Statements

5

BABCOCK & WILCOX ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

			Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands, except per share amounts)			2026						2025						2026						2025
Revenues			$	290,795					$	139,226					$	824,925					$	426,680
Costs and expenses:
Cost of operations			245,947						105,876						689,984						324,108
Selling, general and administrative expenses			30,541						29,124						108,615						90,760
Research and development costs			551						295						1,973						1,585
Impairment of long-lived assets			—						—						—						950
(Gain) loss on asset disposals, net			(39)						557						445						730
Total costs and expenses			277,000						135,852						801,017						418,133
Operating income			13,795						3,374						23,908						8,547
Other (expense) income:
Interest expense			(4,094)						(8,500)						(13,549)						(30,534)
Interest income			1,285						356						2,675						1,133
(Loss) gain on debt extinguishment			(569)						1,730						(628)						1,730
Benefit plans, net			429						(783)						1,285						(2,338)
Foreign exchange			(1,239)						(1,271)						(1,336)						(83)
Change in fair value of customer warrants			85,144						—						20,760						—
Other income (expense), net			156						(281)						(497)						(877)
Total other income (expense)			81,112						(8,749)						8,710						(30,969)
Income (loss) from continuing operations before income tax expense			94,907						(5,375)						32,618						(22,422)
Income tax expense			1,395						780						4,473						6,725
Income (loss) from continuing operations			93,512						(6,155)						28,145						(29,147)
Income (loss) from discontinued operations, net of tax			398						41,247						3,075						(16,260)
Net income (loss) attributable to stockholders			93,910						35,092						31,220						(45,407)
Less: Dividend on Series A Preferred Stock			3,715						3,715						11,145						11,145
Net income (loss) attributable to stockholders of common stock			$	90,195					$	31,377					$	20,075					$	(56,552)
Basic earnings (loss) per share:
Continuing operations			$	0.61					$	(0.10)					$	0.12					$	(0.41)
Discontinued operations			—						0.40						0.02						(0.16)
Basic earnings (loss) per share			$	0.61					$	0.30					$	0.14					$	(0.57)
Diluted earnings (loss) per share:
Continuing operations			$	0.02					$	(0.10)					$	(0.05)					$	(0.41)
Discontinued operations			—						0.40						0.02						(0.16)
Diluted earnings (loss) per share			$	0.02					$	0.30					$	(0.03)					$	(0.57)
Shares used in the computation of earnings (loss) per share:
Basic			147,275						103,047						141,170						99,918
Diluted			158,739						103,047						149,030						99,918

See accompanying notes to the Condensed Consolidated Financial Statements.

6

BABCOCK & WILCOX ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

			Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands)			2026						2025						2026						2025
Net income (loss) attributable to stockholders			$	93,910					$	35,092					$	31,220					$	(45,407)
Other comprehensive income (loss):
Currency translation adjustments			18						4,170						(1,750)						6,769
Reclassification of currency translation adjustments to net income (loss)			—						13,981						—						66,627
Pension and postretirement adjustments, net of tax			—						124						—						371
Other comprehensive income (loss)			18						18,275						(1,750)						73,767
Total comprehensive income			93,928						53,367						29,470						28,360
Comprehensive income attributable to non-controlling interest			—						—						—						(23)
Comprehensive income attributable to stockholders			$	93,928					$	53,367					$	29,470					$	28,337

See accompanying notes to the Condensed Consolidated Financial Statements.

7

BABCOCK & WILCOX ENTERPRISES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands, except per share amounts)			September 30, 2026						December 31, 2025
Cash and cash equivalents			$	71,159					$	89,456
Current restricted cash			28,994						84,991
Accounts receivable – trade, net of allowance for credit losses of $2.0 million and $2.1 million as of September 30, 2026 and December 31, 2025, respectively			260,011						118,383
Contracts in progress			102,153						72,808
Inventories, net			62,478						60,880
Customer contract asset current			13,513						8,268
Other current assets			37,193						35,890
Total current assets			575,501						470,676
Net property, plant and equipment and finance leases			77,631						65,533
Goodwill			52,154						53,097
Intangible assets, net			12,651						15,267
Right-of-use assets			16,265						17,651
Long-term restricted cash			28,714						26,913
Deferred tax assets			913						945
Customer contract asset noncurrent			52,386						—
Other assets			28,529						12,856
Total assets			$	844,744					$	662,938
Accounts payable			$	162,889					$	69,192
Accrued employee benefits			6,625						4,575
Advance billings on contracts			58,834						111,987
Accrued warranty expense			3,377						3,584
Financing lease liabilities			2,095						1,894
Operating lease liabilities			3,557						3,819
Customer warrants			51,777						8,268
Other accrued liabilities			31,281						32,129
Current senior notes			—						83,873
Current borrowings			333						67,373
Total current liabilities			320,768						386,694
Borrowings, net of current portion			55,610						18,865
Senior Notes due 2030			146,572						150,970
Pension and other postretirement benefit liabilities			153,001						176,191
Finance lease liabilities, net of current portion			25,240						26,742
Operating lease liabilities, net of current portion			13,809						15,125
Deferred tax liability			10,462						10,666
Other noncurrent liabilities			9,633						9,226
Total liabilities			735,095						794,479
Stockholders' equity (deficit):
Preferred Stock, par value $0.01 per share, authorized shares of 20,000; issued and outstanding shares of 7,669 at September 30, 2026 and December 31, 2025			77						77
Common stock, par value $0.01 per share, authorized shares of 500,000; issued and outstanding shares of 145,446 and 130,447 at September 30, 2026 and December 31, 2025, respectively			5,824						5,569
Capital in excess of par value			1,967,180						1,691,412
Treasury stock at cost, 7,633 and 2,690 shares at September 30, 2026 and December 31, 2025, respectively			(169,044)						(115,886)
Accumulated deficit			(1,676,660)						(1,696,735)
Accumulated other comprehensive loss			(17,728)						(15,978)
Total stockholders' equity (deficit)			109,649						(131,541)
Total liabilities and stockholders' equity (deficit)			$	844,744					$	662,938

See accompanying notes to the Condensed Consolidated Financial Statements.

8

BABCOCK & WILCOX ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

(Unaudited)

						Common Stock												Preferred Stock												Capital In Excess of Par Value						Treasury Stock						Accumulated Deficit						Accumulated Other Comprehensive Loss												Total Stockholders' Equity (Deficit)
(in thousands)						Shares						Par  Value						Shares						Par  Value
Balance at December 31, 2025						130,447						$	5,569					7,669						$	77					$	1,691,412					$	(115,886)					$	(1,696,735)					$	(15,978)											$	(131,541)
Net loss						—						—						—						—						—						—						(76,945)						—												(76,945)
Currency translation adjustments						—						—						—						—						—						—						—						(916)												(916)
Equity pension contribution						740						63						—						—						6,244						—						—						—												6,307
Stock-based compensation and employee tax withholdings						611						11						—						—						6,799						(6,172)						—						—												638
Dividends to preferred stockholders						—						—						—						—						—						—						(3,715)						—												(3,715)
Common stock offering, net						3,949						39						—						—						34,038						—						—						—												34,077
Balance at March 31, 2026						135,747						$	5,682					7,669						$	77					$	1,738,493					$	(122,058)					$	(1,777,395)					$	(16,894)											$	(172,095)
Net income						—						—						—						—						—						—						14,255						—												14,255
Currency translation adjustments						—						—						—						—						—						—						—						(852)												(852)
Stock-based compensation and employee tax withholdings						551						6						—						—						1,645						(1,849)						—						—												(198)
Repurchase of common stock						(234)						—						—						—						—						(4,960)						—						—												(4,960)
Dividends to preferred stockholders						—						—						—						—						—						—						(3,715)						—												(3,715)
Common stock offering, net						12,898						130						—						—						224,804						—						—						—												224,934
Balance at June 30, 2026						148,962						$	5,818					7,669						$	77					$	1,964,942					$	(128,867)					$	(1,766,855)					$	(17,746)											$	57,369
Net income						—						—						—						—						—						—						93,910						—												93,910
Currency translation adjustments						—						—						—						—						—						—						—						18												18
Stock-based compensation and employee tax withholdings						347						6						—						—						2,238						(2,280)						—						—												(36)
Repurchase of common stock						(3,863)						—						—						—						—						(37,897)						—						—												(37,897)
Dividends to preferred stockholders						—						—						—						—						—						—						(3,715)						—												(3,715)
Balance at September 30, 2026						145,446						$	5,824					7,669						$	77					$	1,967,180					$	(169,044)					$	(1,676,660)					$	(17,728)											$	109,649

9

BABCOCK & WILCOX ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

(Unaudited)

						Common Stock												Preferred Stock												Capital In Excess of Par Value						Treasury Stock						Accumulated Deficit						Accumulated Other Comprehensive Loss						Non-controlling Interest						Total Stockholders' Equity (Deficit)
(in thousands)						Shares						Par  Value						Shares						Par Value
Balance at December 31, 2024						95,138						$	5,208					7,669						$	77					$	1,558,828					$	(115,500)					$	(1,645,716)					$	(86,660)					$	591					$	(283,172)
Net loss						—						—						—						—						—						—						(22,007)						—						18						(21,989)
Currency translation adjustments						—						—						—						—						—						—						—						403						4						407
Pension and post retirement adjustments, net of tax						—						—						—						—						—						—						—						124						—						124
Stock-based compensation and employee tax withholdings						—						—						—						—						760						—						—						—						—						760
Dividends to preferred stockholders						—						—						—						—						—						—						(3,715)						—						—						(3,715)
Common stock offering, net						3,266						32						—						—						5,155						—						—						—						—						5,187
Dividends to non-controlling interest						—						—						—						—						—						—						—						—						(118)						(118)
Balance at March 31, 2025						98,404						$	5,240					7,669						$	77					$	1,564,743					$	(115,500)					$	(1,671,438)					$	(86,133)					$	495					$	(302,516)
Net loss						—						$	—					—						$	—					$	—					$	—					$	(58,492)					$	—					$	26					$	(58,466)
Currency translation adjustments						—						—						—						—						—						—						—						54,842						19						54,861
Pension and post retirement adjustments, net of tax						—						—						—						—						—						—						—						123						—						123
Stock-based compensation and employee tax withholdings						531						5						—						—						728						—						—						—						—						733
Dividends to preferred stockholders						—						—						—						—						—						—						(3,715)						—						—						(3,715)
Common stock offering, net						254						3						—						—						291						—						—						—						—						294
Balance at June 30, 2025						99,189						$	5,248					7,669						$	77					$	1,565,762					$	(115,500)					$	(1,733,645)					$	(31,168)					$	540					$	(308,686)
Net income						—						$	—					—						$	—					$	—					$	—					$	35,092					$	—					$	16					$	35,108
Currency translation adjustments						—						—						—						—						—						—						—						18,151						—						18,151
Pension and postretirement adjustments, net of tax						—						—						—						—						—						—						—						124						—						124
Stock-based compensation and employee tax withholdings						439						12						—						—						741						(386)						—						—						—						367
Dividends to preferred stockholders						—						—						—						—						—						—						(3,715)						—						—						(3,715)
Common stock offering, net						11,472						115						—						—						26,885						—						—						—						—						27,000
Divestiture of non-controlling interest						—						—						—						—						—						—						—						—						(556)						(556)
Balance at September 30, 2025						111,100						$	5,375					7,669						$	77					$	1,593,388					$	(115,886)					$	(1,702,268)					$	(12,893)					$	—					$	(232,207)

See accompanying notes to the Condensed Consolidated Financial Statements.

10

BABCOCK & WILCOX ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

			Nine Months Ended September 30,
(in thousands)			2026						2025
Operating Activities:
Net income (loss) from continuing operations			$	28,145					$	(29,147)
Net income (loss) from discontinued operations			3,075						(16,260)
Net income (loss)			31,220						(45,407)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization of long-lived assets			8,190						7,754
Impairment of long-lived assets			—						9,917
Amortization of deferred financing costs and debt premium			(2,449)						1,460
Amortization of guaranty fee			—						108
Amortization of customer warrants			6,637						—
Change in fair value of customer warrants			(20,760)						—
Non-cash operating lease expense			2,674						5,163
Gain on sale of business			(3,075)						(17,319)
Loss (gain) on debt extinguishment			628						(1,730)
Loss on asset disposals, net			445						882
Benefit from deferred income taxes, including valuation allowances			(173)						(481)
Prior service cost amortization for pension and postretirement plans			(1,285)						371
Stock-based compensation			12,873						2,245
Foreign exchange			1,336						(5,726)
Unrealized loss on securities			83						2,151
Bad debt expense			125						45
Changes in operating assets and liabilities:
Accounts receivable – trade, net			(152,895)						(6,284)
Contracts in progress			(29,345)						11,922
Other current and noncurrent assets			(2,417)						(8,191)
Advance billings on contracts			(53,153)						16,600
Inventories, net			(1,598)						(6,131)
Income taxes			(7,351)						(98)
Accounts payable			93,173						(33,231)
Accrued and other current liabilities			(741)						12,768
Accrued contract loss			3,135						(4,504)
Pension liabilities, accrued postretirement benefits and employee benefits			(14,613)						(6,765)
Other, net			(922)						(1,419)
Net cash used in operating activities			(130,258)						(65,900)
Investing Activities:
Purchase of property, plant and equipment			(18,606)						(12,594)
Proceeds from sale of business and assets			3,948						187,450
Purchases of securities			(6,451)						(5,592)
Sales and maturities of securities			6,303						3,155
Net cash (used in) provided by investing activities			(14,806)						172,419

11

BABCOCK & WILCOX ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

			Nine Months Ended September 30,
(in thousands)			2026						2025
Financing Activities:
Borrowings on loan payable			10,971						75,418
Repayments on loan payable			(41,287)						(126,825)
Issuance of Senior Notes due 2030			—						5,400
Buyback of Senior Notes due 2026			(84,792)						(6,282)
Finance lease payments			(1,433)						(1,242)
Payment of Preferred Stock dividends			(11,145)						(11,145)
Employee tax withholding on stock-based compensation			(10,301)						(386)
Issuance of common stock, net			259,580						32,481
Payment of non-controlling interest dividends			—						(118)
Repurchase of common stock			(42,857)						—
Debt issuance costs			(5,514)						(4,418)
Other, net			—						(259)
Net cash provided by (used in) financing activities			73,222						(37,376)
Effects of exchange rate changes on cash			(651)						878
Net (decrease) increase in cash, cash equivalents and restricted cash			(72,493)						70,021
Cash, cash equivalents and restricted cash at beginning of period			201,360						131,064
Cash, cash equivalents and restricted cash at end of period			$	128,867					$	201,085
Schedule of cash, cash equivalents and restricted cash:
Cash and cash equivalents (1)			$	71,159					$	25,218
Current restricted cash			28,994						165,527
Long-term restricted cash			28,714						10,340
Total cash, cash equivalents and restricted cash at end of period			$	128,867					$	201,085
Supplemental cash flow information:
Income taxes paid, net			$	10,690					$	8,135
Interest paid			13,497						24,803

(1) Includes cash held at discontinued operations of $0.8 million at September 30, 2025.

See accompanying notes to the Condensed Consolidated Financial Statements.

12

BABCOCK & WILCOX ENTERPRISES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

SEPTEMBER 30, 2026

NOTE 1 – BASIS OF PRESENTATION

These interim Condensed Consolidated Financial Statements of Babcock & Wilcox Enterprises, Inc. ("B&W," "management," "we," "us," "our" or the "Company") have been prepared in accordance with GAAP and SEC instructions for interim financial information and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2025. The Notes to the Condensed Consolidated Financial Statements are presented on the basis of continuing operations, unless otherwise stated.

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. In the opinion of management, these Condensed Consolidated Financial Statements contain all estimates and adjustments, consisting of normal recurring adjustments, required to fairly present the financial position, results of operations and cash flows for the periods presented. Operating results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the full-year ending December 31, 2026. Certain prior period amounts were reclassified to conform to the presentation in the current period.

There have been no material changes to our significant accounting policies included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025.

Operations

Our operations are assessed based on one reportable segment as described in Note 5. For financial information about our segment see Note 5 to the Condensed Consolidated Financial Statements.

13

NOTE 2 – EARNINGS (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted earnings (loss) per share of our common stock, net of non-controlling interest and dividends on Preferred Stock:

			Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands, except per share amounts)			2026						2025						2026						2025
Income (loss) from continuing operations			$	93,512					$	(6,155)					$	28,145					$	(29,147)
Less: Dividend on Series A Preferred Stock			3,715						3,715						11,145						11,145
Income (loss) from continuing operations attributable to stockholders of common stock			89,797						(9,870)						17,000						(40,292)
Income (loss) from discontinued operations, net of tax			398						41,247						3,075						(16,260)
Net income (loss) attributable to stockholders of common stock used to calculated basic earnings (loss) per share			$	90,195					$	31,377					$	20,075					$	(56,552)
Income (loss) from continuing operations attributable to stockholders of common stock used to calculate basic earnings (loss) per share			$	89,797					$	(9,870)					$	17,000					$	(40,292)
Dilutive effect of warrants, net of tax			(86,881)						—						(24,620)						—
Income (loss) from continuing operations attributable to stockholders of common stock used to calculated diluted earnings (loss) per share			2,916						(9,870)						(7,620)						(40,292)
Income (loss) from discontinued operations, net of tax			398						41,247						3,075						(16,260)
Net income (loss) attributable to stockholders of common stock used to calculated diluted earnings (loss) per share			$	3,314					$	31,377					$	(4,545)					$	(56,552)
Weighted average shares used to calculate basic earnings (loss) per share			147,275						103,047						141,170						99,918
Dilutive effect of stock options, restricted stock, performance units and warrants			11,464						—						7,860						—
Weighted average shares used to calculate diluted earnings (loss) per share			158,739						103,047						149,030						99,918
Basic earnings (loss) per share:
Continuing operations			$	0.61					$	(0.10)					$	0.12					$	(0.41)
Discontinued operations			—						0.40						0.02						(0.16)
Basic earnings (loss) per share			$	0.61					$	0.30					$	0.14					$	(0.57)
Diluted earnings (loss) per share:
Continuing operations			$	0.02					$	(0.10)					$	(0.05)					$	(0.41)
Discontinued operations			—						0.40						0.02						(0.16)
Diluted earnings (loss) per share			$	0.02					$	0.30					$	(0.03)					$	(0.57)

In accordance with GAAP, dilution is assessed on the basis of continuing operations. We incurred a net loss from continuing operations in the three and nine months ended September 30, 2025, therefore basic and diluted shares are the same for those periods.

We excluded 2.0 million and 0.7 million shares related to stock-based compensation awards from the diluted share calculation for the three months ended September 30, 2026 and 2025, respectively, because their effect would have been anti-dilutive. We excluded 4.4 million and 2.1 million shares related to stock-based compensation awards and warrants from the diluted share calculation for the nine months ended September 30, 2026 and 2025, respectively, because their effect would have been anti-dilutive.

14

NOTE 3 – DIVESTITURES

Vølund

In April 2025, Babcock & Wilcox A/S ("BWAS"), a subsidiary of the Company, sold substantially all of its assets, including intellectual property, specific project contracts as well as related agreements with suppliers and certain tangible assets, to Kanadevia Inova Denmark A/S (the "Buyer"). The sale was comprised of a simultaneous transfer of assets from BWAS to a newly incorporated BWAS subsidiary (the "NewCo") pursuant to a business transfer agreement ("BTA"), and sale of NewCo by BWAS to the Buyer pursuant to a share purchase agreement (together with the BTA, the "Purchase Agreements").

The Purchase Agreements provided for a base purchase price equal to $15.0 million plus $0.1 million (400,000 Danish krone), subject to certain offsets and adjustments, including additional payments to BWAS if the Buyer enters into a certain prospective project agreement within five years. In addition, BWAS and the Buyer entered into an agreement under which the Buyer loaned BWAS $5.0 million which will be considered repaid when BWAS transfers to NewCo certain retained intellectual property usage rights. The Purchase Agreements also included representations and warranties regarding BWAS and the transferred business and assets, as well as certain indemnities with respect thereto. During the nine months ended September 30, 2025, we recorded a net loss of $36.8 million, which included a write off of CTA of $52.6 million.

Diamond Power

In June 2025, we through our wholly owned subsidiaries, The Babcock & Wilcox Company, Babcock & Wilcox International Sales and Service Corporation, and Babcock & Wilcox Canada Corp. (collectively, the "Sellers") entered into an agreement (the "Purchase Agreement") to sell to certain legal entities affiliated with Andritz AG the equity interests of Diamond Power and related legal entities together with assets related to the Diamond Power business. We closed the sale in July 2025.

The Purchase Agreement provided for a base purchase price equal to $177 million, subject to certain offsets and adjustments. The Purchase Agreement also included representations and warranties regarding the sale, as well as certain indemnities with respect thereto. The Purchase Agreement also included an undertaking for the Sellers and their affiliates not to compete with the Diamond Power business or to solicit customers or employees with respect to the Diamond Power business for a period of four years. Additionally, we entered into an agreement to provide transition services to the Diamond Power business for a period of 12 months, or until earlier agreed upon with respect to certain services. We recorded a gain of $53.2 million on the sale in the three and nine months ended September 30, 2025. For the three and nine months ended September 30, 2026, we recorded additional gains of $0.4 million and $3.9 million, respectively, as part of the settlement of certain outstanding items in accordance with the agreement, which is reported in Income (loss) from discontinued operations, net of tax in the Condensed Consolidated Statements of Operations.

ASH

In October 2025, we completed a sale of the net assets comprising our ASH business to Andritz AG for $29.0 million, subject to customary fees and adjustments. In conjunction with the transaction, we and Andritz AG, through certain wholly-owned subsidiaries, signed sales representative agreements under which we will continue to market ASH and Diamond Power products and services to customers in the utility power sectors. We recorded a gain of $21.5 million on the sale in the fourth quarter of 2025.

B&W Solar

In December 2025, the B&W Solar business was disposed of through abandonment, as we ceased all business operations and either transferred or wrote off its remaining assets. No impairment charges were recognized as part of the abandonment.

BWRS

In June 2024, we, through our B&W PGG Luxembourg Finance Sárl subsidiary, sold all issued and outstanding share capital of our Denmark-based renewable parts and services subsidiary, BWRS, to Hitachi Zosen Inova AG. We received net cash proceeds of $83.5 million and recorded a gain on the sale of the business of $44.9 million during the year ended December 31, 2024. In the first quarter of 2025, we recorded a gain of $1.0 million and in the first quarter of 2026 we recorded a loss of

15

$0.9 million, as part of settlement negotiations with the buyer, each of which are reported in Income (loss) from discontinued operations, net of tax in the Condensed Consolidated Statements of Operations.

NOTE 4 – DISCONTINUED OPERATIONS

During 2024 and 2025, we engaged in a strategy and developed a formalized plan to divest certain non-core businesses to reduce our debt, improve our balance sheet and increase liquidity. As of December 31, 2025, we have divested our BWRS, SPIG, GMAB, Vølund, Diamond Power, ASH and B&W Solar businesses as part of this plan. The Company has completed this strategic initiative and no additional divestitures are planned at this time.

Results of operations of the divested subsidiaries are reported as discontinued operations for all periods presented and the notes to the financial statement have been adjusted on a retrospective basis. Our divestitures are described further in Note 3 to the Condensed Consolidated Financial Statements.

The following tables summarize the operating results of the disposal groups included in discontinued operations in the Condensed Consolidated Statements of Operations:

			Three Months Ended September 30, 2025
(in thousands)			B&W Solar						Vølund						Diamond Power						ASH						Total
Revenues			$	2,116					$	2,764					$	8,085					$	9,781					$	22,746
Cost of operations			2,783						4,206						5,596						5,864						18,449
Selling, general and administrative expenses			4,202						1,387						7,653						654						13,896
Research and development costs			—						20						(39)						6						(13)
Impairment of long-lived assets			14						—						—						—						14
Total costs and expenses			6,999						5,613						13,210						6,524						32,346
Operating (loss) income			(4,883)						(2,849)						(5,125)						3,257						(9,600)
Other (expense) income			(106)						178						58						803						933
(Loss) income from discontinued operations, before tax			(4,989)						(2,671)						(5,067)						4,060						(8,667)
Income tax expense			—						12						2,977						247						3,236
Gain on divestiture			—						—						53,166						—						53,166
(Loss) income from discontinued operations, net of tax			(4,989)						(2,683)						45,122						3,813						41,263
Less: Net income attributable to non-controlling interest from discontinued operations			—						—						(16)						—						(16)
(Loss) income attributable to stockholders from discontinued operations			$	(4,989)					$	(2,683)					$	45,106					$	3,813					$	41,247

16

			Nine Months Ended September 30, 2025
(in thousands)			B&W Solar						BWRS						Vølund						Diamond Power						ASH						Total
Revenues			$	12,149					$	—					$	4,815					$	63,053					$	22,189					$	102,206
Cost of operations			24,050						—						16,811						40,595						13,688						95,144
Selling, general and administrative expenses			7,360						—						6,163						15,198						2,041						30,762
Research and development costs			—						—						488						367						14						869
Impairment of long-lived assets			7,846						—						1,121						—						—						8,967
Loss on asset disposals, net			16						—						136						—						—						152
Total costs and expenses			39,272						—						24,719						56,160						15,743						135,894
Operating (loss) income			(27,123)						—						(19,904)						6,893						6,446						(33,688)
Other (expense) income			(533)						—						2,901						1,067						473						3,908
(Loss) income from discontinued operations, before tax			(27,656)						—						(17,003)						7,960						6,919						(29,780)
Income tax expense			—						—						120						3,448						171						3,739
Gain (loss) on divestiture			—						1,014						(36,861)						53,166						—						17,319
(Loss) income from discontinued operations, net of tax			(27,656)						1,014						(53,984)						57,678						6,748						(16,200)
Less: Net income attributable to non-controlling interest from discontinued operations			—						—						—						(60)						—						(60)
(Loss) income attributable to stockholders from discontinued operations			$	(27,656)					$	1,014					$	(53,984)					$	57,618					$	6,748					$	(16,260)

17

The depreciation, amortization, capital expenditures and significant operating and investing noncash items of the discontinued operations are as follows:

			Nine Months Ended September 30, 2025
(in thousands)			B&W Solar						Vølund						Diamond Power						ASH						Total
Depreciation and amortization of long-lived assets			$	14					$	—					$	397					$	12					$	423
Changes in operating assets and liabilities:
Accounts receivable – trade, net			1,145						4,445						18,168						(1,856)						21,902
Contracts in progress			672						3,646						3,011						77						7,406
Accounts payable			(12,201)						(2,140)						(8,958)						736						(22,563)
Advance billings on contracts			(26)						(5,115)						(664)						2,247						(3,558)
Purchase of property, plant and equipment			(367)						(2)						(271)						—						(640)

NOTE 5 – SEGMENT REPORTING

Our operations are assessed as one reportable segment, B&W, as revised in the fourth quarter of 2025 due to a strategic shift in our business, including the divestiture of certain non-core assets as described in Note 3 to the Condensed Consolidated Financial Statements. This segment presentation has been applied retrospectively to all periods presented.

The Company's CODM is the Chief Executive Officer and Chairman of the Board of Directors. The CODM assesses performance on a consolidated basis, using the segment's Income (loss) from continuing operations as its profitability metric. The CODM considers budget-to-actual and forecast-to-actual variances on a quarterly basis when making decisions about our operating and capital resources. The measure of segment assets is reported on the Condensed Consolidated Balance Sheets as Total assets.

An analysis of our operations by revenue type is as follows:

			Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands)			2026						2025						2026						2025
B&W
Parts			$	59,003					$	61,201					$	185,183					$	182,966
Projects			122,961						47,265						363,182						128,035
Construction			108,831						30,760						276,560						115,679
Total Revenue			$	290,795					$	139,226					$	824,925					$	426,680

18

The following table presents Revenues, significant expenses and Income (loss) from continuing operations for our consolidated segment:

			Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands)			2026						2025						2026						2025
Revenues			$	290,795					$	139,226					$	824,925					$	426,680
Less:
Cost of operations (1)			244,024						104,385						685,552						320,226
Selling, general and administrative expenses (1)			29,282						27,739						104,857						87,325
Depreciation and amortization (2)			3,182						2,876						8,190						7,317
Interest expense, net			2,809						8,144						10,874						29,401
Benefit plans, net			(429)						783						(1,285)						2,338
Change in fair value of customer warrants			(85,144)						—						(20,760)						—
Other expense, net (3)			2,164						674						4,879						2,495
Income tax expense			1,395						780						4,473						6,725
Income (loss) from continuing operations			$	93,512					$	(6,155)					$	28,145					$	(29,147)

(1) Excludes depreciation and amortization.

(2) Depreciation and amortization is included in Cost of operations and SG&A in the Condensed Consolidated Statements of Operations.

(3) Other expense, net includes Research and development costs, Impairment of long-lived assets, (Gain) loss on asset disposals, net, (Loss) gain on debt extinguishment and Foreign exchange as presented in the Condensed Consolidated Statements of Operations.

NOTE 6 – REVENUE RECOGNITION AND CONTRACTS

Revenue Recognition

We generate the vast majority of our revenues from the supply of, and aftermarket services for, steam-generating, environmental and auxiliary equipment.

A performance obligation is a contractual promise to transfer a distinct product or service to the customer. A contract's transaction price is allocated to each distinct performance obligation and is recognized as revenue when (point in time) or as (over time) the performance obligation is satisfied.

Revenue from products and services transferred to customers over time, which primarily relates to customized, engineered solutions and construction services, accounted for more than 90% of revenue for the three and nine months ended September 30, 2026 and 2025. Revenue from products and services transferred to customers at a point in time, which includes certain aftermarket parts and services, accounted for less than 10% of revenue for the three and nine months ended September 30, 2026 and 2025.

See Note 5 to the Condensed Consolidated Financial Statements for further disaggregation of revenue.

Base Electron Agreement

Effective February 26, 2026, we entered into a written definitive agreement with Base Electron, to complete the design and installation of four 300-megawatt natural gas-fired power plants. The total consideration in exchange for completion of this project is $2.4 billion, of which $2.0 billion is for variable charges and the remaining is a fixed fee. The variable charges are based on reimbursable costs incurred plus mark-up. The plant is targeted to begin commercial operation in 2030.

Revenue for this project is recognized over time as we satisfy our performance obligation. For the three and nine months ended September 30, 2026, we have recognized $77.8 million and $209.5 million of revenue related to this contract, respectively.

19

Contract Balances

The following represents the components of Accounts receivable – trade, net, Contracts in progress and Advance billings on contracts included in the Condensed Consolidated Balance Sheets. Also included are accrued contract losses, which are presented in Other accrued liabilities in the Condensed Consolidated Balance Sheets:

(in thousands)			September 30, 2026						December 31, 2025						$ Change						% Change
Accounts receivable – trade, net (1)			$	260,011					$	118,383					$	141,628					120		%
Contracts in progress			102,153						72,808						29,345						40		%
Advance billings on contracts (2)			58,834						111,987						(53,153)						(47)		%
Accrued contract losses			3,604						469						3,135						668		%

(1) Includes $147.8 million related to Base Electron as of September 30, 2026. There was no balance outstanding as of December 31, 2025.

(2) Includes $6.0 million related to Base Electron as of September 30, 2026. There was no balance outstanding as of December 31, 2025.

(in thousands)			September 30, 2025						December 31, 2024						$ Change						% Change
Accounts receivable – trade, net			$	97,064					$	91,767					$	5,297					6		%
Contracts in progress			70,590						79,149						(8,559)						(11)		%
Advance billings on contracts			75,760						56,381						19,379						34		%
Accrued contract losses			1						217						(216)						(100)		%

For each of the nine months ended September 30, 2026 and 2025, we recognized 95% and 93% of the revenue related to amounts that were included in Advance billings on contracts as of December 31, 2025 and 2024, respectively.

Backlog

At September 30, 2026, we had $2.5 billion of remaining performance obligations, which we also refer to as total backlog. We expect to recognize approximately 10%, 28% and 62% of the remaining performance obligations as revenue in 2026, 2027 and thereafter, respectively.

NOTE 7 – INVENTORIES, NET

Inventories are stated at the lower of cost or net realizable value. Certain raw material inventory is sold to our customers directly and without further processing. The components of Inventories, net included in the Condensed Consolidated Balance Sheets are as follows:

(in thousands)			September 30, 2026						December 31, 2025
Raw materials and supplies			$	59,338					$	58,337
Work in progress			2,981						2,361
Finished goods			159						182
Total inventories, net			$	62,478					$	60,880

20

NOTE 8 – PROPERTY, PLANT AND EQUIPMENT AND FINANCE LEASES

The following table indicates the carrying value of land and each of the major classes of depreciable assets in the Condensed Consolidated Balance Sheets:

(in thousands)			September 30, 2026						December 31, 2025
Land			$	2,265					$	1,493
Buildings			16,650						16,557
Machinery and equipment			51,673						100,937
Property under construction			36,106						19,520
			106,694						138,507
Less accumulated depreciation			49,218						94,612
Net property, plant and equipment			57,476						43,895
Finance leases			34,081						33,960
Less finance lease accumulated amortization			13,926						12,322
Net property, plant and equipment and finance leases			$	77,631					$	65,533

NOTE 9 – GOODWILL

Goodwill represents the excess of the consideration transferred over the fair value of net assets, including identifiable intangible assets, at the acquisition date. Goodwill is assessed for impairment annually on October 1 or more frequently if events or changes in circumstances indicate a potential impairment exists.

There were no indicators of goodwill impairment identified for the quarter ended September 30, 2026.

The following summarizes the changes in the net carrying amount of Goodwill in the Condensed Consolidated Balance Sheets:

(in thousands)
Balance at December 31, 2025			$	53,097
Currency translation adjustments			(943)
Balance at September 30, 2026			$	52,154

21

NOTE 10 – INTANGIBLE ASSETS, NET

Intangible assets are as follows:

(in thousands)			September 30, 2026						December 31, 2025
Definite-lived intangible assets
Customer relationships			$	25,705					$	26,406
Unpatented technology			3,278						3,701
Patented technology			1,413						1,912
Tradename			1,804						1,828
All other			275						275
Gross value of definite-lived intangible assets			32,475						34,122
Customer relationships amortization			(15,717)						(14,367)
Unpatented technology amortization			(1,345)						(1,470)
Patented technology amortization			(1,154)						(1,441)
Tradename amortization			(1,333)						(1,302)
All other amortization			(275)						(275)
Accumulated amortization			(19,824)						(18,855)
Total intangible assets, net			$	12,651					$	15,267

The following summarizes the changes in the carrying amount of intangible assets, net:

(in thousands)			September 30, 2026						December 31, 2025
Balance at beginning of period			$	15,267					$	17,640
Amortization expense			(2,194)						(2,947)
Currency translation adjustments			(422)						574
Balance at end of the period			$	12,651					$	15,267

Amortization of intangible assets is included in Cost of operations and SG&A in the Condensed Consolidated Statements of Operations.

Estimated future intangible asset amortization expense as of September 30, 2026 is as follows:

(in thousands)			Amortization Expense
Year ending December 31, 2026			$	698
Year ending December 31, 2027			2,727
Year ending December 31, 2028			2,539
Year ending December 31, 2029			2,539
Year ending December 31, 2030			2,539
Thereafter			1,609

22

NOTE 11 – ACCRUED WARRANTY EXPENSE

We may offer assurance-type warranties on products and services sold to customers. Changes in the carrying amount of accrued warranty expense are as follows:

(in thousands)			September 30, 2026						December 31, 2025
Balance at beginning of period			$	3,584					$	2,654
Additions			3,734						1,221
Expirations and other changes			(3,490)						(1,498)
Payments			(253)						(98)
Translation and other (1)			(198)						1,305
Balance at end of period			$	3,377					$	3,584

(1) 2025 balance includes $1.3 million of liabilities reclassified from held for sale as of December 31, 2025.

We record estimated expense included in Cost of operations in the Condensed Consolidated Statements of Operations to satisfy contractual warranty requirements when we recognize the associated revenues on the related contracts, or in the case of a loss contract, the full amount of the estimated warranty costs is recognized when the contract becomes a loss contract. In addition, we record specific adjustments when we expect the actual warranty costs to significantly differ from the initial estimates. Factors that impact our estimate of warranty costs include prior history of warranty claims and our estimate of future costs of materials and labor. Such changes could have a material effect on our consolidated financial position, results of operations and cash flows.

NOTE 12 – PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

Components of net periodic benefit (credit) cost included in net income (loss) are as follows:

			Pension Benefits																								Other Benefits
			Three Months Ended September 30,												Nine Months Ended September 30,												Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands)			2026						2025						2026						2025						2026						2025						2026						2025
Interest cost			$	8,859					$	10,012					$	26,583					$	30,036					$	52					$	63					$	156					$	189
Expected return on plan assets			(9,340)						(9,438)						(28,024)						(28,325)						—						—						—						—
Amortization of prior service cost			—						75						—						225						—						71						—						213
Benefit plans, net			(481)						649						(1,441)						1,936						52						134						156						402
Service cost (1)			—						100						—						300						5						5						15						15
Net periodic benefit (credit) cost			$	(481)					$	749					$	(1,441)					$	2,236					$	57					$	139					$	171					$	417

(1)    Service cost related to a small group of active participants is presented within Cost of operations in the Condensed Consolidated Statements of Operations.

There were no MTM adjustments for the pension and other postretirement benefit plans during the three and nine months ended September 30, 2026 and 2025.

We made contributions to the pension and other postretirement benefit plans totaling $13.8 million and $20.5 million during the three and nine months ended September 30, 2026 as compared to $7.4 million and $15.1 million during the three and nine months ended September 30, 2025, respectively.

23

NOTE 13 – DEBT AND CREDIT FACILITIES

Senior Notes Due 2026

During the nine months ended September 30, 2026, we redeemed $84.8 million of our 6.50% Senior Notes, settling the debt obligation in full.

The components of our Senior Notes due 2026 at December 31, 2025 were as follows:

(in thousands)			6.50%
Senior Notes due 2026			$	84,792
Unamortized deferred financing costs			(919)
Net debt balance (1)			$	83,873

(1) Included in Current senior notes in the Condensed Consolidated Balance Sheets.

Senior Notes Due 2030

The components of our Senior Notes due 2030 are as follows:

			8.75% (1)
(in thousands)			September 30, 2026						December 31, 2025
Senior Notes due 2030			$	129,473					$	129,473
Unamortized deferred financing costs			(4,905)						(5,867)
Unamortized premium			22,004						27,364
Net debt balance			$	146,572					$	150,970

(1) The 8.75% Senior Notes mature in June 2030 and are included in Senior Notes due 2030 in the Condensed Consolidated Balance Sheets at September 30, 2026 and December 31, 2025. As of September 30, 2026, the 8.75% Senior Notes bear an effective interest rate of 5.5%.

In May 2025, we completed privately negotiated exchange transactions (the "Exchanges") in which we issued $100.7 million aggregate principal amount of newly-issued 8.75% Senior Secured Second Lien Notes due 2030 as consideration for $84.0 million aggregate principal amount of our 8.125% Senior Notes and $47.8 million aggregate principal amount of our 6.50% Senior Notes. As a result of the Company's financial situation as a going concern entity at the time of refinancing, and the fact the creditors had granted concessions, the Exchanges were accounted for as a troubled debt restructuring. Therefore, the Company recognized the difference between the face value of the original Senior Notes due 2026 and the face value of the 8.75% Senior Notes as debt premium, which is amortized using the effective interest method over the 5-year term through May 2030.

Credit Agreement with Axos

We entered into the Credit Agreement in January 2024, with certain of our subsidiaries as guarantors, the lenders party thereto from time to time and Axos, as administrative agent, swingline lender and letter of credit issuer.

The Credit Agreement provides for an up to $150.0 million asset-based Credit Facility, including a $100.0 million letter of credit sublimit. Our obligations under the Credit Agreement are guaranteed by certain of our domestic and foreign subsidiaries. B. Riley originally provided a guaranty of payment with regard to our obligations under the Credit Agreement; however, this guaranty is no longer in place due to the Tenth Amendment as further described below. We used and expect to use the proceeds and letter of credit availability under the Credit Agreement to (i) provide for working capital needs, (ii) provide cash collateral to secure letters of credit to be issued under the Credit Agreement and (iii) provide for general corporate purposes.

The Credit Agreement has a maturity date of January 18, 2028 as amended by the Tenth Amendment. The interest rates applicable under the Credit Agreement are: (i) with respect to SOFR Loans, (a) SOFR plus 5.25% for the outstanding principal amount of loans up to $100.0 million, plus (b) SOFR plus 4.00% for the outstanding principal amount of $100.0 million and higher; (ii) with respect to Base Rate Loans, the greater of (a) the Federal Funds Rate plus 2.00% plus the Applicable Margin, (b) the prime rate as designated by Axos plus the Applicable Margin and (c) Daily Simple SOFR plus

24

1.00% plus the Applicable Margin; and (iii) with respect to the default rate under the Credit Agreement, the then-existing interest rate plus 2.00%.

In connection with the Credit Agreement, we are required to pay (i) a commitment fee equal to 0.50% per annum multiplied by the positive difference by which the Aggregate Revolving Commitments exceed the Total Revolvings Outstanding (as defined in the Credit Agreement), subject to adjustment, (ii) a facility fee equal to the Applicable Margin for SOFR Loans multiplied by the positive difference by which the actual daily amount of L/C Obligations the Administrative Agent is then holding Specified Cash Collateral exceeds the actual daily Outstanding Amount of Revolving Loans, and (iii) a collateral monitoring fee of $1,000 per month. We are permitted to prepay all or any portion of the loans under the Credit Agreement prior to maturity, subject to the payment of an early termination fee. The Credit Agreement requires mandatory prepayments under certain circumstances, including in the event of an overadvance.

The obligations under the Credit Agreement are secured by substantially all assets of B&W and each of the guarantors, in each case subject to intercreditor arrangements. The Credit Agreement contains certain representations and warranties, affirmative covenants, negative covenants and conditions that are customarily required for similar financings. The Credit Agreement requires us to comply with certain financial maintenance covenants, including a quarterly fixed charge coverage test, a quarterly total net leverage ratio test, a cash repatriation covenant, a minimum liquidity covenant, an annual cap on maintenance capital expenditures and a limit on unrestricted cash.

The Credit Agreement also contains customary events of default (subject, in certain instances, to specified grace periods) including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal under the Credit Agreement, the failure to comply with certain covenants and agreements specified in the Credit Agreement, defaults in respect of certain other indebtedness, and certain events of insolvency. If any event of default occurs, Axos may declare the principal, premium, if any, interest and any other monetary obligations on all the then outstanding amounts under the Credit Agreement may become due and payable immediately. At September 30, 2026, after giving consideration to the Amendments to the Credit Agreement, we are in compliance with all financial and other covenants contained in the Credit Agreement.

The key terms of the Credit Agreement described above reflect the various amendments completed since the original Credit Agreement was entered into and reflect changes in the Company's capital structure, borrowing base, collateral requirements and financial covenant levels. These amendments addressed, among other items, (i) authorization of specified asset dispositions, (ii) adjustments to borrowing base components, including increases in inventory valuation percentages and changes to PBGC reserve requirements, (iii) temporary and permanent modifications to minimum liquidity thresholds, (iv) deferral or modification of certain covenant ratios, (v) add‑backs related to discontinued operations and capital expenditures for covenant calculations and (vi) updates to maturity provisions tied to the refinancing or repayment of other outstanding debt instruments.

On February 25, 2026, the Company with certain subsidiaries of the Company as guarantors, B. Riley, and the lenders party to the Credit Agreement with Axos, as administrative agent, entered into the Tenth Amendment to the Credit Agreement. Pursuant to the Tenth Amendment, Axos and the Lenders party to the Credit Agreement consented to amend certain provisions of the Credit Agreement to, among other things, (i) increase the amounts available to be borrowed based on inventory and receivables in the borrowing base under the Credit Agreement; (ii) extend the maturity date of the Credit Agreement to January 18, 2028; (iii) suspend the PBGC Reserve (provided that the PBGC Reserve shall be re-imposed in the amount of $3.0 million on January 1, 2027 unless the Company has provided evidence to Axos that the $3.0 million installment due to the PBGC on or prior to September 15, 2026 has been paid); (iv) modify the covenants relating to deposit account control agreements and institutions to allow for certain holdings in foreign currencies; and (v) release B. Riley as a specified guarantor thereunder.

On August 11, 2026, we entered into the Eleventh Amendment to the Credit Agreement, which modified certain financial covenant calculations and restricted payment provisions, including the authorization of our share repurchase program. Our share repurchase program is described further in Note 14 to the Condensed Consolidated Financial Statements.

At September 30, 2026, we had a total of $36.9 million outstanding on the Credit Agreement, all of which is drawn on the letter of credit portion of the agreement. At September 30, 2026, cash collateralizing the letters of credit totaling $36.9 million is classified as Current and Long-term restricted cash included in the Condensed Consolidated Balance Sheets.

25

A summary of usage of letters of credit under domestic facilities is as follows:

(in thousands)			September 30, 2026						December 31, 2025
Letters of credit under domestic facilities:
Performance letters of credit			$	20,875					$	45,236
Financial letters of credit			11,963						14,365
Total outstanding			$	32,838					$	59,601
Backstopped letters of credit			$	1,200					$	7,194
Surety backstopped letters of credit			2,017						16,452
Letters of credit subject to currency revaluation			14,580						27,105

Other Letters of Credit, Bank Guarantees and Surety Bonds

Certain of our subsidiaries, that are primarily outside of the United States, have credit arrangements with various commercial banks and other financial institutions for the issuance of letters of credit and bank guarantees in association with contracting activity.

We have posted surety bonds to support contractual obligations to customers relating to certain contracts. We utilize bonding facilities to support such obligations, but the issuance of bonds under those facilities is typically at the surety's discretion. These bonds generally indemnify customers should we fail to perform our obligations under our applicable contracts. We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds the underwriters issue in support of some of our contracting activity.

The following table provides a summary of outstanding letters of credit issued outside of the domestic facilities, and outstanding surety bonds:

(in thousands)			September 30, 2026						December 31, 2025
Letters of credit under non-domestic facilities			$	1,166					$	6,545
Surety Bonds			245,206						253,407

Our ability to obtain and maintain sufficient capacity under our current debt facilities is essential to allow us to support the issuance of letters of credit, bank guarantees and surety bonds. Without sufficient capacity, our ability to support contract security requirements in the future will be diminished.

Other Loans Payable

As of September 30, 2026 and December 31, 2025, we had loans payable of approximately $8.2 million and $8.4 million, net of debt issuance costs of $0.5 million, related to sale-leaseback financing transactions.

As of September 30, 2026 and December 31, 2025, we had loans payable of $5.0 million owed to the State of West Virginia relating to our BrightLoop™ project. The loan will be forgiven in full when certain employment and capital expenditure milestones are met during the course of the project.

26

Interest expense in the Condensed Consolidated Financial Statements consisted of the following components:

			Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands)			2026						2025						2026						2025
Components associated with borrowings from:
Credit Agreement			$	3					$	469					$	10					$	2,734
Senior Notes due 2026			412						3,893						2,719						15,414
Senior Notes due 2030			2,888						2,426						8,552						3,464
			3,303						6,788						11,281						21,612
Components associated with amortization or accretion of:
Credit Agreement			715						901						1,636						3,987
Senior Notes due 2026			78						396						534						1,540
Senior Notes due 2030			(1,335)						(1,247)						(4,397)						(1,824)
			(542)						50						(2,227)						3,703
Components associated with interest from:
Lease liabilities			539						603						1,687						1,839
Letter of credit interest			853						1,309						3,271						3,201
Other interest expense			232						391						500						820
Capitalized interest			(291)						(641)						(963)						(641)
			1,333						1,662						4,495						5,219
Total Interest expense			$	4,094					$	8,500					$	13,549					$	30,534

NOTE 14 – CAPITAL STOCK

Preferred Stock

During the nine months ended September 30, 2026, our Board of Directors approved dividends totaling $11.1 million to holders of the Preferred Stock. There were no cumulative undeclared dividends of the Preferred Stock at September 30, 2026, and all declared dividends have been paid as of September 30, 2026.

Sale of Common Stock

In April 2024, we entered into the Sales Agreement with the Agents, in connection with an at-the-market offering. For the nine months ended September 30, 2025, 15.0 million shares were sold pursuant to the Sales Agreement, for net proceeds of $32.5 million.

In November 2025, we entered into the 2025 Sales Agreement with the 2025 Agents, in connection with the offer and sale from time to time of shares of our common stock, having an aggregate offering price of up to $200.0 million through the 2025 Agents. For the nine months ended September 30, 2026, 4.4 million shares have been sold pursuant to the 2025 Sales Agreement for net proceeds of $41.9 million.

On May 18, 2026, we completed a public offering of our common stock pursuant to an underwriting agreement dated May 14, 2026, between us and B. Riley, as representative of several underwriters. At closing, we issued 12.4 million shares of our common stock and received proceeds of $218.2 million, after deducting underwriting discounts and commission fees of $11.8 million. B&W also incurred other offering-related expenses of $1.0 million, which were netted against proceeds received and recorded in Capital in excess of par value on the Condensed Consolidated Balance Sheets.

27

Repurchase of Common Stock

In the second quarter of 2026, we repurchased 0.2 million shares of our common stock from certain members of our Board of Directors for an an aggregate purchase price of $5.0 million. See Note 20 to the Condensed Consolidated Financial Statements for further information.

On July 13, 2026, we announced a share repurchase program of up to $50 million of our outstanding common stock as authorized by our Board of Directors. Under the program, we may repurchase shares from time to time in open-market transactions, in privately negotiated transactions, through block trades or pursuant to trading plans established in accordance with Rule 10b5-1 or Rule 10b-18 under the Exchange Act based on market conditions, share price and other factors. The program does not obligate us to purchase any shares, has no fixed expiration date and may be suspended or discontinued at any time. For the nine months ended September 30, 2026, 3.9 million shares have been purchased under this program for $37.9 million. Of the 3.9 million shares repurchased, 1.3 million were from the Company's pension trust. See Note 20 to the Condensed Consolidated Financial Statements for further information.

Applied Digital/Base Electron Agreements

In November 2025, we entered into a limited notice to proceed ("LNTP") with Applied Digital for a project to design and install four 300-megawatt natural gas-fired power plants consisting of boilers and associated steam turbines to deliver power for an AI factory. Effective February 26, 2026, we entered into a definitive written agreement in relation to the project with Base Electron. The total consideration in exchange for completion of this project is $2.4 billion, of which $2.0 billion is for variable charges and the remaining is a fixed fee. The variable charges are based on reimbursable costs incurred plus mark-up. The plant is targeted to begin commercial operation in 2030.

In connection with the entry into the LNTP, we issued to Applied Digital, in a private placement, (i) 0.5 million shares of common stock, par value $0.01 per share for a purchase price of $2.0 million and (ii) a warrant (the "Initial Warrant") exercisable to purchase 2.6 million shares of our common stock at an exercise price of $4.11, subject to registration rights. The LNTP also granted to Applied Digital an additional warrant (the "Additional Warrant") to purchase up to 7.86 million shares of our common stock, on the same terms as the Initial Warrant. As a result of the signing of the agreement with Base Electron, the Additional Warrant to purchase up to 7.86 million shares of our common stock is fully vested on the same terms as the Initial Warrant.

Effective March 18, 2026, we entered into a Partial Assignment and Assumption Agreement with Applied Digital and Base Electron under which Applied Digital assigned 5.23 million shares of stock under the Initial Warrant and Additional Warrant (collectively the "Warrants") to Base Electron.

The Warrants are classified as liability-based awards which require calculation of fair value for each reporting period until settled or expired. As of September 30, 2026 and December 31, 2025, we calculated the fair value of the Initial Warrant at $12.9 million and $8.3 million, respectively, and as of September 30, 2026, we calculated the fair value of the Additional Warrant at $38.9 million, each of which are recorded in Customer warrants on the Condensed Consolidated Balance Sheets. The Change in fair value of customer warrants is primarily driven by fluctuations in the Company's stock price, which decreased as of September 30, 2026 comparative to June 30, 2026 and December 31, 2025 for the Initial Warrant, and also decreased as of September 30, 2026 comparative to June 30, 2026 and the February 26, 2026 grant date stock price for the Additional Warrant issued. As a result, we recorded other income of $85.1 million and $20.8 million for the three and nine months ended September 30, 2026, respectively, both of which are recorded in Change in fair value of customer warrants in the Condensed Consolidated Statements of Operations.

Since the Warrants were issued as part of the Base Electron project, a corresponding asset was calculated as of the grant date of each warrant and is amortized over the life of the agreement with Base Electron. As of September 30, 2026 and December 31, 2025, the asset balances were $65.9 million and $8.3 million, respectively, and recorded in Customer contract asset current and noncurrent in the Condensed Consolidated Balance Sheets. For the three and nine months ended September 30, 2026, amortization expense of $2.5 million and $6.6 million was recognized as a reduction to Revenues in the Condensed Consolidated Statements of Operations.

28

We used the following assumptions to determine the fair value of the Warrants granted as of September 30, 2026 and December 31, 2025:

			September 30, 2026						December 31, 2025
Risk-free interest rate			5.10		%				3.84		%
Expected volatility			100.0		%				105.0		%
Exercise price			$	4.11					$	4.11
Remaining term of warrant			6.1 years						7 years

The fair value of the Warrants is categorized within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs, including expected volatility. In making these assumptions, we based risk-free rates on the corresponding U.S. Treasury spot rates for the remaining duration of the grant, which we convert to a continuously compounded rate. We based estimated volatility on the historical returns of our stock price and selected guideline companies over the remaining term of the grant.

NOTE 15 – SUPPLEMENTAL CASH FLOW INFORMATION

The following table provides a reconciliation of Cash and cash equivalents and Current and Long-term restricted cash reported within the Condensed Consolidated Balance Sheets and in the Condensed Consolidated Statements of Cash Flows:

(in thousands)			September 30, 2026						December 31, 2025
Held by foreign entities			$	10,265					$	9,048
Held by U.S. entities			60,894						80,408
Cash and cash equivalents			71,159						89,456
Reinsurance reserve requirements			1,525						2,407
Project indemnity collateral			3,487						32,264
Letters of credit collateral (1)			36,896						66,801
Escrow for long-term project			15,800						10,432
Current and Long-term restricted cash and cash equivalents			57,708						111,904
Total Cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows			$	128,867					$	201,360

(1) Balance drawn on Axos Credit Agreement to serve as collateral on our letters of credit. This is reflected in Current and Long-term restricted cash in the Condensed Consolidated Balance Sheets.

NOTE 16 – STOCK-BASED COMPENSATION

2021 Long-Term Incentive Plan Share Authorization

On May 20, 2026, at the 2026 annual meeting of stockholders, the stockholders of the company, upon the recommendation of the Company's Board of Directors, approved an amendment to the Babcock & Wilcox Enterprises, Inc. 2021 Long-Term Incentive Plan. The amendment increased the total number of shares of the Company's common stock authorized for award grants from 5.3 million to 10.3 million. As of September 30, 2026, we had 4.6 million shares available for future grant under the 2021 Long-Term Incentive Plan.

Stock options

There were no stock options awarded during the nine months ended September 30, 2026. As of September 30, 2026, nominal shares were outstanding and exercisable, each with a weighted average exercise price of $41.70 and a weighted average remaining contractual term of 1.2 years. As of December 31, 2025, nominal outstanding and exercisable shares had a weighted average exercise price of $63.57 and $63.55, respectively, and a weighted average remaining contractual term of 1.7 years.

29

Restricted stock units (RSUs)

Non-vested RSU activity for the year-to-date period ended September 30, 2026 is as follows:

(in thousands, except per share amounts)			Number of shares						Weighted-average grant date fair value
Non-vested at beginning of period			2,001						$	1.31
Granted			2,757						10.22
Vested			(1,814)						14.29
Cancelled/forfeited			(1)						14.07
Non-vested at end of period			2,943						$	7.23

As of September 30, 2026, total compensation expense not yet recognized related to non-vested restricted stock units was $18.9 million and the weighted-average period in which the expense is expected to be recognized is 2.8 years. For the nine months ended September 30, 2026 and 2025, compensation expense related to the RSUs was $10.7 million and $2.3 million, respectively.

Restricted stock units with market conditions

In July 2022, we granted market-based RSUs to certain members of management that vest if our closing stock price on the NYSE is equal to or higher than the stock price goal of $12.00 per share. The grant date fair value per market-based RSU was $6.70 and determined using a Monte Carlo simulation approach. On March 5, 2026, our stock price closed at $13.29 per share which triggered the vesting of 0.5 million shares. There was no compensation expense recognized for these awards for the nine months ended September 30, 2026 and 2025, respectively.

Stock Appreciation Rights (SARs)

The Company has outstanding cash-settled SARs held by current and former employees. The SARs may be exercised during specified periods when the Company's stock price exceeds the applicable share price goal. The liability method is used to recognize the accrued compensation expense with cumulatively adjusted revaluations to the then current fair value at each reporting date through final settlement. As of September 30, 2026 and December 31, 2025, we calculated the fair value of the SARs at $1.3 million and nominal, respectively. The SARs are recorded in Accrued employee benefits and Other accrued liabilities in the Condensed Consolidated Balance Sheets.

The change in fair value of the SARs liability for the three and nine months ended September 30, 2026 was $(4.6) million and $1.3 million, respectively, and is recognized in SG&A in the Condensed Consolidated Statements of Operations. The change in the fair value of the SARs from the previous quarter is primarily driven by fluctuations in the Company's stock price, which decreased comparative to the June 30, 2026 stock price.

We used the following assumptions to determine the fair value of the SARs granted as of September 30, 2026 and December 31, 2025:

			September 30, 2026						December 31, 2025
Risk-free interest rate			4.80		%				3.70		%
Expected volatility			110		%				80		%
Expected life in years			2.20						3.25
Suboptimal exercise factor			2.0x						2.0x

The fair value of the SARs is categorized within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs, including expected volatility. In making these assumptions, we based estimated volatility on the historical returns of our stock price and selected guideline companies. We based risk-free rates on the corresponding U.S. Treasury spot rates for the expected duration at the date of grant, which we convert to a continuously compounded rate. We relied upon a suboptimal exercise factor, representing the ratio of the base price to the stock price at the time of exercise, to account for potential early exercise prior to the expiration of the contractual term. With consideration to the executive level of the SARs holders, a

30

suboptimal exercise multiple of 2.0x was selected. Subject to vesting conditions, should the stock price achieve a value of 2.0x above the base price, we assume the holders will exercise prior to the expiration of the contractual term of the SARs. The expected term for the SARs is an output of the valuation model in estimating the time period that the SARs are expected to remain unexercised. The valuation model assumes the holders will exercise their SARs prior to the expiration of the contractual term of the SARs.

As of September 30, 2026 and December 31, 2025, the SARs are fully vested and their total intrinsic value is zero.

NOTE 17 – INCOME TAXES

For the three months ended September 30, 2026, income tax expense from continuing operations was $1.4 million, resulting in an effective tax rate of 1.5%. For the three months ended September 30, 2025, income tax expense from continuing operations was $0.8 million, resulting in an effective tax rate of (14.5)%.

For the nine months ended September 30, 2026, income tax expense from continuing operations was $4.5 million, resulting in an effective tax rate of 13.7%. For the nine months ended September 30, 2025, income tax expense from continuing operations was $6.7 million, resulting in an effective tax rate of (30.0)%.

Our effective tax rate for the three and nine months ended September 30, 2026 is not reflective of the U.S. statutory rate due to certain foreign countries having a tax rate higher than the U.S. statutory rate, valuation allowances against certain net deferred tax assets and favorable discrete items.

We are subject to federal income tax in the United States and numerous countries that have statutory tax rates different than the U.S. federal statutory rate of 21%. We provide for income taxes based on the tax laws and rates in the jurisdictions where we conduct operations. These jurisdictions may have regimes of taxation that vary in both nominal rates and the basis on which these rates are applied. Our consolidated effective income tax rate can vary from period to period due to these foreign income tax rate variations, changes in the jurisdictional mix of our income and valuation allowances.

NOTE 18 – ACCUMULATED OTHER COMPREHENSIVE LOSS

Gains and losses deferred in AOCI are generally reclassified and recognized in the Condensed Consolidated Statements of Operations once they are realized. The changes in the components of AOCI, net of tax, for the three and nine months ended September 30, 2026 and 2025 were as follows:

(in thousands)			Currency translation loss												Net unrecognized loss related to benefit plans (net of tax)						Total
Balance at December 31, 2025			$	(16,156)											$	178					$	(15,978)
Other comprehensive loss			(916)												—						(916)
Balance at March 31, 2026			$	(17,072)											$	178					$	(16,894)
Other comprehensive loss			(852)												—						(852)
Balance at June 30, 2026			$	(17,924)											$	178					$	(17,746)
Other comprehensive income			18												—						18
Balance at September 30, 2026			$	(17,906)											$	178					$	(17,728)

31

(in thousands)			Currency translation loss												Net unrecognized loss related to benefit plans (net of tax)						Total
Balance at December 31, 2024			$	(85,487)											$	(1,173)					$	(86,660)
Other comprehensive income before reclassifications			403												—						403
Reclassification of AOCI to net income (loss)			—												124						124
Net other comprehensive income			403												124						527
Balance at March 31, 2025			$	(85,084)											$	(1,049)					$	(86,133)
Other comprehensive income before reclassifications			2,196												—						2,196
Reclassification of AOCI to net income (loss)			52,646												123						52,769
Net other comprehensive income			54,842												123						54,965
Balance at June 30, 2025			$	(30,242)											$	(926)					$	(31,168)
Other comprehensive income before reclassifications			4,170												—						4,170
Reclassification of AOCI to net income (loss)			13,981												124						14,105
Net other comprehensive income			18,151												124						18,275
Balance at September 30, 2025			$	(12,091)											$	(802)					$	(12,893)

The amounts reclassified out of AOCI by component and the affected Condensed Consolidated Statements of Operations line items are as follows (in thousands):

AOCI component						Line items in the Condensed Consolidated Statements of Operations affected by reclassifications from AOCI						Three Months Ended September 30,												Nine Months Ended September 30,
												2026						2025						2026						2025
Release of currency translation adjustment with the sale of business						Income (loss) from discontinued operations, net of tax						$	—					$	(13,981)					$	—					$	(66,627)
Pension and postretirement adjustments, net of tax						Benefit plans, net						—						(124)						—						(371)
						Net income (loss)						$	—					$	(14,105)					$	—					$	(66,998)

NOTE 19 – FAIR VALUE MEASUREMENTS

The accounting guidance established by ASC 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (known as "Level 1") and the lowest priority to unobservable inputs (known as "Level 3"). Where observable inputs are available for substantially the full term of the asset or liability, the instrument is categorized in Level 2.

The following tables summarize financial assets carried at fair value, all of which were valued from readily available prices (Level 1).

Securities

			Level 1
(in thousands)			September 30, 2026						December 31, 2025
Corporate notes and bonds			$	4,616					$	5,334
United States Government and agency securities			2,588						1,806
Total fair value of securities			$	7,204					$	7,140

32

Investments in securities are presented as $3.5 million in Other current assets and $3.7 million in Other assets as of September 30, 2026 in the Condensed Consolidated Balance Sheets with contractual maturities ranging from 0 to 1.5 years.

Senior Notes due 2030

The fair value of the Senior Notes due 2030 is based on present value of future cash flows discounted at estimated borrowing rates for similar debt instruments or on estimated prices based on current yields for debt issues of similar quality and terms (known as "Level 2") as of September 30, 2026 and December 31, 2025:

			8.75% Senior Notes
(in thousands)			September 30, 2026						December 31, 2025
Carrying value			$	129,473					$	129,473
Estimated fair value			130,431						127,359

Other Financial Instruments

We used the following methods and assumptions in estimating fair value amounts for other financial instruments:

•Cash and cash equivalents and restricted cash and cash equivalents. The carrying amounts reported in the accompanying Condensed Consolidated Balance Sheets for cash and cash equivalents and restricted cash and cash equivalents approximate their fair value due to their highly liquid nature and are classified as Level 1.

•Revolving Debt. We base the fair value of debt instruments on quoted market prices. Where quoted prices are not available, we base the fair value on Level 2 inputs such as the present value of future cash flows discounted at estimated borrowing rates for similar debt instruments or on estimated prices based on current yields for debt issues of similar quality and terms. The fair value of Revolving Debt was calculated at $36.0 million, which is $0.9 million less than its carrying amount at September 30, 2026.

•Applied Digital/Base Electron Warrants. These liability-based awards are categorized within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs. For further information, see Note 14 to the Condensed Consolidated Financial Statements.

•Stock Appreciation Rights. These instruments are categorized within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs. For further information, see Note 16 to the Condensed Consolidated Financial Statements.

NOTE 20 – RELATED PARTY TRANSACTIONS

Transactions with B. Riley

Based on Schedule 13D filings with the SEC, B. Riley beneficially owns approximately 19% of our outstanding common stock as of September 30, 2026. B. Riley currently has the right to nominate one member of our Board of Directors pursuant to the investor rights agreement we entered into with B. Riley in April 2019. The investor rights agreement also provides pre-emptive rights to B. Riley with respect to certain future issuances of our equity securities.

As described in Note 13 to the Condensed Consolidated Financial Statements, in connection with our entry into the Credit Agreement in January 2024, we entered into a guaranty agreement and related fee and reimbursement agreement with B. Riley, pursuant to which B. Riley guaranteed our obligations under the Credit Agreement in exchange for an annual fee of approximately $3.0 million. In June 2025, the B. Riley Guaranty, as well as the associated B. Riley Guaranty fees, were suspended until January 1, 2027 and in February 2026, the guaranty and fee agreement were cancelled.

As described in Note 14 to the Condensed Consolidated Financial Statements, in April 2024 and November 2025, we entered into sales agreements with B. Riley, among others, in connection with the offer and sale from time to time of shares of our common stock. B. Riley is entitled to compensation equal to 3.0% of the gross proceeds from each sale of the shares sold through it as the designated Agent. We have paid $1.3 million and $1.0 million for the nine months ended September 30, 2026 and 2025, respectively, related to this arrangement.

In the first quarter of 2026, we entered into an agreement with B. Riley to provide financial advisory services to the Company. Under this agreement, B. Riley will be paid a cash fee equal to 3.0% of the total financing value of any qualified

33

debt transaction that is consummated, plus a cash fee of $0.5 million for other financial advisory services. For the nine months ended September 30, 2026, we paid $5.0 million related to this agreement. The fee was capitalized and will be amortized over the life of the Credit Agreement.

As described in Note 14 to the Condensed Consolidated Financial Statements, on May 18, 2026, we completed a public offering of our common stock pursuant to an underwriting agreement dated May 14, 2026, between us and B. Riley, as representative of several underwriters. In connection with the offering, we incurred underwriting discounts and commission fees of $11.8 million, which were netted against the total proceeds received.

Transactions with Board of Directors

In the second quarter of 2026, we repurchased 0.2 million shares of our common stock from certain members of our Board of Directors. These shares were previously issued pursuant to stock awards granted in connection with their service as directors. We paid an aggregate purchase price of $5.0 million, equivalent to the market price of shares at the time of repurchase. The transaction was recorded in Treasury stock within Stockholders' equity (deficit) on the Condensed Consolidated Balance Sheet.

Repurchase of Common Stock from Pension Trust

In the third quarter of 2026, we repurchased 1.3 million shares of our common stock from the Company's pension trust for $12.7 million. The transaction was completed pursuant to a share repurchase program at a price of $10.14 per share, based on the two-day volume weighted average price per share immediately before the date of the agreement, August 18, 2026. The transaction was settled in cash and no amounts remain payable to the trust as of September 30, 2026. The transaction was recorded in Treasury stock within Stockholders' equity (deficit) on the Condensed Consolidated Balance Sheet. Our share repurchase program is described further in Note 14 to the Condensed Consolidated Financial Statements.

NOTE 21 – NEW ACCOUNTING PRONOUNCEMENTS AND STANDARDS

We did not adopt any new accounting pronouncements during the nine months ended September 30, 2026.

New Accounting Standards to be Adopted

We consider the applicability and impact of all issued ASUs. Certain recently issued ASUs were assessed and determined to not be applicable. New accounting standards not yet adopted that could affect the Condensed Consolidated Financial Statements in the future are summarized as follows:

In October 2023, FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative ("ASU 2023-06"). The new guidance is intended to align GAAP and SEC requirements while facilitating the application of GAAP for all entities. The effective date of ASU 2023-06 depends on (1) whether an entity is already subject to the SEC's current disclosure requirements and (2) whether and, if so, when the SEC removed related requirements from its regulations. For entities that are already subject to the SEC's current disclosure requirements, the effective date for each amendment will be the date on which the SEC's removal of that related disclosure requirement from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. If the SEC has not removed the related requirements from its regulations by June 30, 2027, the amendments made by ASU 2023-06 will be removed from the Codification and will not become effective for any entity. The impact of this standard on the Company's Condensed Consolidated Financial Statements is contingent upon future transactions.

In November 2024, FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"). The new guidance is intended to improve financial reporting by requiring all public business entities to disclose additional information about specific expense categories. ASU 2024-03 is effective for annual periods beginning after December 15, 2026. Early adoption is permitted. Further, in January 2025, FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). ASU 2025-01 is clarifying the effective dates outlined in ASU 2024-03 which is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027, and may be applied either prospectively or retrospectively. We are currently evaluating the impact of this standard on the Condensed Consolidated Financial Statements.

34

In December 2025, FASB issued ASU 2025-10, Government Grants: Accounting for Government Grants Received by Business Entities ("ASU 2025-10"). The new guidance is intended to help business entities in determining how to recognize, measure and present these grants. ASU 2025-10 is effective for annual periods beginning after December 15, 2028. Early adoption is permitted. We are currently evaluating the impact of this standard on the Condensed Consolidated Financial Statements.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial position and results of operations should be read in conjunction with the financial statements and the notes thereto included in the Condensed Consolidated Financial Statements in Item 1 of this Quarterly Report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements as a result of many factors, including those described in more detail under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with the SEC. See also "Cautionary Statement Concerning Forward-Looking Information" herein. Unless otherwise noted, discussion of our business and results of operations refers to our continuing operations.

BUSINESS OVERVIEW

We are a globally focused energy technologies provider with nearly 160 years of experience providing diversified energy and emissions control solutions to a broad range of industrial, electrical utility, municipal and other customers. Our innovative products and services are organized in one reportable segment.

Customer demand is heavily affected by the variations in our customers' business cycles, power demand in their operating territories, and by the overall economies, energy, environmental and regulatory requirements of the countries in which they operate.

We have manufacturing facilities in Canada, Mexico and the United States. Many aspects of our operations and properties could be affected by political developments, environmental regulations and operating risks. These and other factors may have

a material impact on our international and domestic operations or our business as a whole.

An increase in power demand has caused a nationwide boilermaker as well as other trade shortfall in skilled labor. These labor constraints have increased construction costs and affected productivity on certain projects. To the extent these conditions persist, they may adversely impact future project execution and operating results.

Discontinued Operations

For more information on our discontinued operations, see Notes 3 and 4 to the Condensed Consolidated Financial Statements.

Vølund

In April 2025, we sold our Vølund business for a base purchase price equal to $15.0 million plus $0.1 million (400,000 Danish krone). We recorded a net loss of $36.8 million, which included a write off of CTA of $52.6 million.

Diamond Power

In July 2025, we closed the sale of our Diamond Power business for a base purchase price of $177 million, subject to certain offsets and adjustments, and recorded a gain of $53.2 million on the sale. For the three and nine months ended September 30, 2026, we recorded additional gains of $0.4 million and $3.9 million, respectively, as part of the settlement of certain outstanding items in accordance with the agreement.

ASH

In October 2025, we completed a sale of the net assets comprising our ASH business for $29 million, subject to customary fees and adjustments, and recorded a gain of $21.5 million on the sale.

35

B&W Solar

As of December 31, 2025, B&W Solar was disposed of through abandonment, as we ceased all business operations and either transferred or wrote off its remaining assets.

BWRS

In June 2024, we, through our B&W PGG Luxembourg Finance Sárl subsidiary, sold all issued and outstanding share capital

of our Denmark-based renewable parts and services subsidiary, BWRS, to Hitachi Zosen Inova AG. In the first quarter of 2026, we recorded a loss of $0.9 million as part of settlement negotiations with the buyer.

RESULTS OF OPERATIONS

Condensed Consolidated Results of Operations

The following discussion reflects the consolidated results of our operations.

			Three Months Ended September 30,																		Nine Months Ended September 30,
(in thousands)			2026						2025						$ Change						2026						2025						$ Change
Revenues			$	290,795					$	139,226					$	151,569					$	824,925					$	426,680					$	398,245
Costs and expenses:
Cost of operations			245,947						105,876						140,071						689,984						324,108						365,876
Selling, general and administrative expenses			30,541						29,124						1,417						108,615						90,760						17,855
Research and development costs			551						295						256						1,973						1,585						388
Impairment of long-lived assets			—						—						—						—						950						(950)
(Gain) loss on asset disposals, net			(39)						557						(596)						445						730						(285)
Operating income			13,795						3,374						10,421						23,908						8,547						15,361
Interest expense			(4,094)						(8,500)						4,406						(13,549)						(30,534)						16,985
Change in fair value of customer warrants			85,144						—						85,144						20,760						—						20,760
Income tax expense			1,395						780						615						4,473						6,725						(2,252)
Income (loss) from continuing operations			$	93,512					$	(6,155)					$	99,667					$	28,145					$	(29,147)					$	57,292

Three Months Ended September 30, 2026 and 2025

Revenues increased by $151.6 million to $290.8 million in the three months ended September 30, 2026 compared to $139.2 million in the three months ended September 30, 2025. The increase is primarily driven by an increase in large project volume, including $77.8 million from Base Electron. This improvement is primarily due to the increasing need for electricity from fossil fuels driven by the demand from AI, data centers and expanding economies.

Cost of operations increased by $140.1 million to $245.9 million in the three months ended September 30, 2026 compared to $105.9 million in the three months ended September 30, 2025. The increase is primarily driven by the higher revenue as described above as well as the product mix of higher large project volume which carries higher costs needed to complete certain projects. In addition, construction costs have increased due to a nationwide shortage of skilled labor, which has caused lower than expected productivity on certain job sites.

36

SG&A expenses increased by $1.4 million to $30.5 million in the three months ended September 30, 2026 compared to $29.1 million in the three months ended September 30, 2025. The increase is primarily driven by higher employee compensation expense, reflecting increased volume from revenue growth during the period.

Research and development costs slightly increased by $0.3 million to $0.6 million in the three months ended September 30, 2026 compared to $0.3 million in the three months ended September 30, 2025. The increase is primarily driven by our BrightLoop™ investment.

(Gain) loss on asset disposals, net increased by $0.6 million to a slight gain in the three months ended September 30, 2026 compared to a $0.6 million loss in the three months ended September 30, 2025, primarily due to minor disposals in the third quarter of 2026.

Operating income increased by $10.4 million to $13.8 million in the three months ended September 30, 2026 compared to Operating income of $3.4 million in the three months ended September 30, 2025. The increase is primarily due to the revenue increase and increased gross profit, partially offset by the increased SG&A expenses noted above.

Income from continuing operations increased by $99.7 million to $93.5 million in the three months ended September 30, 2026 compared to a loss of $6.2 million in the three months ended September 30, 2025. The increase is primarily driven by the improvement in the operating income results noted above. We also benefited from the change in fair value of customer warrants of $85.1 million and a reduction to interest expense of $4.4 million.

Nine Months Ended September 30, 2026 and 2025

Revenues increased by $398.2 million to $824.9 million in the nine months ended September 30, 2026 compared to $426.7 million in the nine months ended September 30, 2025. The increase is primarily driven by an increase in large project volume, including $209.5 million from Base Electron. This improvement is primarily due to the increasing need for electricity from fossil fuels driven by the demand from AI, data centers and expanding economies.

Costs of operations increased by $365.9 million to $690.0 million in the nine months ended September 30, 2026 compared to $324.1 million in the nine months ended September 30, 2025. The increase is primarily driven by the mix of the business as large project volume increased, resulting in higher costs needed to complete certain projects. In addition, construction costs have increased due to a nationwide shortage of skilled labor, which has caused lower than expected productivity on certain job sites.

SG&A expenses increased by $17.9 million to $108.6 million in the nine months ended September 30, 2026 compared to $90.8 million in the nine months ended September 30, 2025. The increase is driven by an increase in employee compensation expense, including stock-based compensation awards, reflecting increased volume from revenue growth during the period.

Research and development costs increased by $0.4 million to $2.0 million in the nine months ended September 30, 2026 compared to $1.6 million in the nine months ended September 30, 2025. The increase is primarily driven by general investment in research and technology.

Impairment of long-lived assets decreased by $1.0 million in 2026 due to an impairment recognized in 2025 relating to a reduction in our real estate footprint.

(Gain) loss on asset disposals decreased by $0.3 million to $0.4 million in the nine months ended September 30, 2026 compared to $0.7 million in the nine months ended September 30, 2025, primarily related to minor disposals in 2026.

Operating income increased by $15.4 million to $23.9 million in the nine months ended September 30, 2026 compared to $8.5 million in the nine months ended September 30, 2025, primarily due to the increased revenue and gross profit, partially offset by the increased SG&A expenses noted above.

Income from continuing operations increased by $57.3 million to $28.1 million compared to a loss of $29.1 million in the nine months ended September 30, 2025. The increase was driven by the improvement in operating income results noted above and the non-cash change in fair value of customer warrants of $20.8 million. Also contributing to the increase in income are reductions in income tax expense of $2.3 million and interest expense of $17.0 million.

37

Other Expenses Impacting Operating Results

Interest Expense

			Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands)			2026						2025						2026						2025
Components associated with borrowings from:
Credit Agreement			$	3					$	469					$	10					$	2,734
Senior Notes due 2026			412						3,893						2,719						15,414
Senior Notes due 2030			2,888						2,426						8,552						3,464
			3,303						6,788						11,281						21,612
Components associated with amortization or accretion of:
Credit Agreement			715						901						1,636						3,987
Senior Notes due 2026			78						396						534						1,540
Senior Notes due 2030			(1,335)						(1,247)						(4,397)						(1,824)
			(542)						50						(2,227)						3,703
Components associated with interest from:
Lease liabilities			539						603						1,687						1,839
Letter of credit interest			853						1,309						3,271						3,201
Other interest expense			232						391						500						820
Capitalized interest			(291)						(641)						(963)						(641)
			1,333						1,662						4,495						5,219
Total Interest expense			$	4,094					$	8,500					$	13,549					$	30,534

Interest expense for the three and nine months ended September 30, 2026 is lower compared to the three and nine months ended September 30, 2025 due to the debt refinancing and paydown transactions that occurred in 2025 as well as the redemption of our 6.50% Senior Notes in August 2026 that results in lower base principal and will result in accretion of the gain on exchange over the life of the debt. See Note 13 to the Condensed Consolidated Financial Statements for further details.

Change in Fair Value of Customer Warrants

The Change in fair value of customer warrants is primarily driven by fluctuations in the Company's stock price, which decreased as of September 30, 2026 comparative to June 30, 2026 and December 31, 2025 for the Initial Warrant, and also decreased as of September 30, 2026 comparative to June 30, 2026 and the February 26, 2026 grant date stock price for the Additional Warrant issued. As a result, we recorded income of $85.1 million for the three months ended September 30, 2026, and income of $20.8 million for the nine months ended September 30, 2026.

Income Taxes

			Three Months Ended September 30,																		Nine Months Ended September 30,
(in thousands, except for percentages)			2026						2025						Change						2026						2025						Change
Income (loss) from continuing operations before income tax expense			$	94,907					$	(5,375)					$	100,282					$	32,618					$	(22,422)					$	55,040
Income tax expense			1,395						780						615						4,473						6,725						(2,252)
Effective tax rate			1.5		%				(14.5)		%										13.7		%				(30.0)		%

Our effective tax rate for the three and nine months ended September 30, 2026 is not reflective of the U.S. statutory rate primarily due to certain foreign countries having a tax rate higher than the U.S. statutory rate, valuation allowances against certain net deferred tax assets and favorable discrete items. In certain jurisdictions where we anticipate a loss for the year or incur a loss for the year-to-date period for which a tax benefit cannot be realized in accordance with ASC 740, we exclude the loss in that jurisdiction from the overall computation of the estimated annual effective tax rate.

38

Deferred tax assets are evaluated each period to determine whether realization is more likely than not. Valuation allowances are established when management determines it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. Valuation allowances may be removed in the future if sufficient positive evidence exists to outweigh the negative evidence under the framework of ASC 740, Income Taxes ("ASC 740").

Bookings and Backlog

Bookings and backlog are our measures of remaining performance obligations under our sales contracts. We believe these metrics provide investors, lenders and other users of our financial statements with a leading indicator of future revenues. It is possible that our methodology for determining bookings and backlog may not be comparable to methods used by other companies.

We generally include expected revenue from contracts in our backlog when we receive written confirmation from our customers authorizing the performance of work and committing our customers to pay for work performed. Backlog may not be indicative of future operating results and contracts in our backlog may be canceled, modified or otherwise altered by customers. Backlog can vary significantly from period to period, particularly when large new-build conversion projects or operations and maintenance contracts are booked because they may be fulfilled over multiple years. Because we operate globally, our backlog is also affected by changes in foreign currencies each period.

Bookings represent changes to the backlog. Bookings include additions related to new business or increases in project scope, subtractions due to customer cancellations or reductions in project scope, changes in estimates that affect selling price and revaluation of backlog denominated in foreign currency. We believe comparing bookings on a quarterly basis or for periods less than one year is less meaningful than for longer periods, and that shorter-term changes in bookings may not necessarily indicate a material trend.

Total bookings for the three and nine months ended September 30, 2026 and 2025 were as follows:

			Three Months Ended September 30,												Nine Months Ended September 30,
(in millions)			2026						2025						2026						2025
B&W (1)			$	227.9					$	107.6					$	2,890.9					$	337.6

(1) Bookings of $2.4 billion were related to Base Electron for the nine months ended September 30, 2026.

Our backlog as of September 30, 2026 and 2025 was as follows:

			As of September 30,
(in millions)			2026						2025
B&W			$	2,510.0					$	374.0

Of the backlog at September 30, 2026, we expect to recognize revenues as follows:

(in millions)			2026						2027						Thereafter						Total
B&W			$	258.6					$	705.9					$	1,545.5					$	2,510.0

Non-GAAP Financial Measures

In addition to Income (loss) from continuing operations, we use non-GAAP financial measures internally to evaluate our performance and make financial and operational decisions. When viewed in conjunction with GAAP results and the accompanying reconciliations, we believe that the presentation of these measures provides investors with greater transparency and a greater understanding of factors affecting our financial position and results of operations than GAAP measures alone. The presentation of non-GAAP financial measures should not be considered in isolation or as a substitute for the related financial results prepared in accordance with GAAP.

The following discussion of our business segment results of operations includes a discussion of EBITDA and Adjusted EBITDA. EBITDA focuses on the earnings generated from core business operations, without considering the effects of financing, accounting decisions or tax. EBITDA and Adjusted EBITDA differ from the most directly comparable measure

39

calculated in accordance with GAAP. A reconciliation of Income (loss) from continuing operations, the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA is included below. Management believes that this financial measure is useful to investors because it excludes certain expenses, allowing investors to more easily compare our financial performance period to period. When viewed in conjunction with GAAP results, we believe the presentation of EBITDA and Adjusted EBITDA provides investors with greater transparency and a greater understanding of factors affecting our financial position and results of operations than GAAP measures alone.

Adjusted EBITDA is calculated as earnings before interest, tax, depreciation and amortization, and adjusted for items such as gains or losses arising from the sale of non-income producing assets, net pension benefits, stock-based compensation, restructuring activities, impairments, gains and losses on debt extinguishment, legal and settlement costs, costs related to financial consulting and amortization and valuation of customer warrants. Additionally, the Company redefined its definition of Adjusted EBITDA to eliminate the effects of certain items including interest on letters of credit included in Cost of operations and product development costs. Prior period results have been revised to conform with the revised definition and present separate reconciling items in our reconciliation.

			Three Months Ended September 30,												Nine Months Ended September 30,
(in thousands)			2026						2025						2026						2025
Income (loss) from continuing operations			$	93,512					$	(6,155)					$	28,145					$	(29,147)
Interest expense, net			2,809						8,144						10,874						29,401
Income tax expense			1,395						780						4,473						6,725
Depreciation & amortization			3,182						2,876						8,190						7,317
EBITDA			100,898						5,645						51,682						14,296
Impairment of long-lived assets			—						—						—						950
Benefit plans, net			(429)						783						(1,285)						2,338
(Gain) loss on asset disposals, net			(39)						557						445						730
Stock-based compensation			(1,950)						746						12,873						2,267
Restructuring activities			6						—						2,518						111
Loss (gain) on debt extinguishment			569						(1,730)						628						(1,730)
Settlements and related legal costs			64						322						107						858
Foreign exchange			1,239						1,271						1,336						83
Financial advisory services			124						1,588						845						6,755
Customer warrant amortization			2,494						—						6,637						—
Change in fair value of customer warrants			(85,144)						—						(20,760)						—
Other – net			(156)						251						497						684
Adjusted EBITDA			$	17,676					$	9,433					$	55,523					$	27,342

Impairment of long-lived assets

Impairment of long-lived assets refers to when the carrying amount of an asset exceeds the fair value or recoverable amount.

Benefit plans, net

We recognize pension and other postretirement benefit income or expense based on actuarial calculations. The net impact depends on the relationship between the expected return on plan assets and the cost of providing benefits. Benefit costs are relatively low because our plans are frozen, meaning employees are no longer earning additional benefits.

Reported pension results may vary due to mark‑to‑market adjustments, which reflect changes in interest rates, asset performance or one‑time events such as plan settlements or curtailments. These adjustments are driven by market conditions and actuarial assumptions as of the date of the event. Because mark‑to‑market impacts are inherently volatile and often event‑driven, any gain or loss recognized in a given period should not be considered indicative of future pension income or expense.

40

See Note 12 to the Condensed Consolidated Financial Statements for further information regarding our pension and other postretirement plans.

(Gain) loss on asset disposals, net

We, at times, will sell or dispose of certain assets that are unrelated to our current or future operations. Therefore, we believe it is useful to exclude these gains and losses from our non-GAAP financial measures in order to highlight the performance of the continuing business.

Stock-based compensation

The grant date fair value of stock-based compensation varies based on the derived stock price at the time of grant, valuation methodologies, subjective assumptions and reward types. This may make the impact of this form of compensation on our current financial results difficult to compare to previous and future periods. Therefore, we believe it is useful to exclude stock-based compensation from our non-GAAP financial measures in order to highlight the performance of the business and to be consistent with the way many investors evaluate our performance and compare our operating results to peer companies.

Restructuring activities

Restructuring activities and business services transition actions across our business units and corporate functions primarily consist of severance and related costs associated with non-recurring actions taken to transform our operations with impacts on employees and facilities used in our businesses. Business services transition costs relate to new technology implementation, expected to provide future benefit and are included in Cost of operations and SG&A expenses in the Condensed Consolidated Statements of Operations.

(Loss) gain on debt extinguishment

Losses (gains) on debt extinguishment are due to the exit costs or benefits associated with our repurchases and settlements of outstanding debt. See Note 13 to the Condensed Consolidated Financial Statements for additional details on the repayment or settlement activity for the periods presented.

Settlements and related legal costs

Settlements and related legal costs relate to expenses associated with resolving legal disputes, whether through negotiated settlements or court judgments.

Foreign exchange

Foreign exchange gains and losses are primarily related to settlement of transactions denominated in a currency different than the functional currency of the Company. We report foreign currency transaction gains (losses) in income in the Condensed Consolidated Statements of Operations. Management excludes these expenses from Adjusted EBITDA as they do not reflect the ordinary course of business and are inherently unpredictable in timing and amount.

Financial advisory services

Financial advisory services relate to financial and business planning and other professional services.

Customer warrant amortization

Customer warrants are amortized over the life of the associated agreement and recorded as a reduction to Revenues in the Condensed Consolidated Statements of Operations. Management excludes the reduction to revenue from Adjusted EBITDA as they are a non-cash transaction and do not reflect the ordinary course of business.

See Note 14 to the Condensed Consolidated Financial Statements for further information regarding our Customer warrant amortization.

41

Change in fair value of customer warrants

Change in fair value of customer warrants is recognized as a gain or loss in the Condensed Consolidated Statements of Operations. Management excludes the expense from Adjusted EBITDA as they are a non-cash transaction and do not reflect the ordinary course of business.

See Note 14 to the Condensed Consolidated Financial Statements for further information regarding our Change in fair value of customer warrants.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

Our primary liquidity requirements include debt service, funding dividends on Preferred Stock and working capital needs. We fund our liquidity requirements primarily through cash generated from operations, external sources of financing, including our Credit Agreement, senior notes, equity offerings and our Preferred Stock, each of which are described below and in the Notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report in further detail. We believe that our current operating plan and borrowings available under our Credit Agreement will be sufficient to satisfy our foreseeable liquidity needs and capital expenditure requirements, including for at least the next twelve months. We may elect to raise additional capital through the sale of additional equity or debt financing to fund business activities such as strategic acquisitions, capital expenditures, working capital needs or other purposes beyond the next twelve months. Additional financing may not be available on terms favorable to us or at all, and may also be impacted by any disruptions in the financial markets. In addition, our existing indebtedness could limit our ability to obtain additional financing.

Cash and Cash Flows

The following discussion on our cash flows is inclusive of continued and discontinued operations, consistent with our presentation on the Condensed Consolidated Statements of Cash Flows in accordance with GAAP.

At September 30, 2026, our cash and cash equivalents, and restricted cash totaled $128.9 million, and we had total debt of $202.5 million, of which $22.0 million is unamortized premium. We also had $191.7 million of gross Preferred Stock outstanding. Our foreign cash was $10.3 million of our total cash and cash equivalents and restricted cash as of September 30, 2026. In general, our foreign cash balances are not available to fund our U.S. operations unless the funds are repatriated or used to repay intercompany loans made from the U.S. to foreign entities, which could expose us to taxes we have not made a provision for in our results of operations. We have no plans to repatriate these funds to the U.S. We had $36.9 million of restricted cash as of September 30, 2026 related to collateral for certain letters of credit as part of funding for several ongoing projects.

Cash flows used in operating activities was $130.3 million in the nine months ended September 30, 2026, which is primarily attributable to movements in certain operating assets and liabilities, such as increases to accounts receivable trade, net of $152.9 million related to larger projects and contracts in progress of $29.3 million, and decreases in advance billings on contracts of $53.2 million, partially offset by increases in accounts payable of $93.2 million. Also offsetting these movements is net income of $31.2 million and non-cash stock compensation expense of $12.9 million, partially offset by the change in fair value of customer warrants of $20.8 million, which is also non-cash. Advance billings on contracts and construction in progress are primarily impacted by timing differences related to progress made on ongoing projects, billings, and collections, and may fluctuate significantly period to period. Operating cash flow decreases from pension liabilities, accrued postretirement benefits and employee benefits of $14.6 million is a result of contributions made to the plan.

Cash flows used in operating activities was $65.9 million in the nine months ended September 30, 2025, which was primarily attributable to the year-to-date net loss of $45.4 million and non-cash adjustments arising from gain on sale of business of $17.3 million, partially offset by the impairment of long-lived assets of $9.9 million. Cash flows used in operating activities also included movements in certain operating assets and liabilities such as decreases in accounts payable of $33.2 million and increases in accounts receivable trade, net of $6.3 million, partially offset by decreases in contracts in progress of $11.9 million and increases in advanced billings on contracts of $16.6 million, which are primarily impacted by timing differences related to progress made on ongoing projects, billings, and collections and may fluctuate significantly period to period. Operating cash flow decreases from pension liabilities, accrued postretirement benefits and employee benefits of $6.8 million

42

is a result of contributions made to the plan. Operating cash flow increases from accrued and other current liabilities of $12.8 million is the result of timing of payments to vendors offset by the decrease in accounts payable of $33.2 million.

Cash flows used in investing activities was $14.8 million in the nine months ended September 30, 2026, primarily due to purchases of fixed assets relating to BrightLoop™ projects, partially offset by proceeds from the sale of businesses and other asset disposals of $3.9 million. Cash flows provided by investing activities were $172.4 million in the nine months ended September 30, 2025, primarily due to proceeds from the sale of our Vølund and Diamond Power businesses of $187.5 million, partially offset by purchases of fixed assets relating to BrightLoop™ projects.

Cash flows provided by financing activities was $73.2 million in the nine months ended September 30, 2026, primarily related to the proceeds of $259.6 million pursuant to our equity offerings as described in Note 14 to the Condensed Consolidated Financial Statements, partially offset by buybacks of our Senior Notes due 2026 of $84.8 million, net repayments on the Credit Agreement of $30.3 million, repurchases of Common stock of $42.9 million and Preferred Stock dividend payments of $11.1 million. Cash flows used in financing activities was $37.4 million in the nine months ended September 30, 2025, primarily related to net repayments on the Credit Agreement of $51.4 million and Preferred Stock dividend payments of $11.1 million, partially offset by proceeds of $32.5 million pursuant to our equity offering as described in Note 14 to the Condensed Consolidated Financial Statements.

Debt and Credit Facility

Information related to our debt and Credit Facility is described in Note 13 to the Condensed Consolidated Financial Statements and is incorporated herein by reference.

Share Repurchase Program

Information related to our share repurchase program is described in Note 14 to the Condensed Consolidated Financial Statements and is incorporated herein by reference.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

For a summary of the critical accounting policies and estimates that we use in the preparation of our unaudited Condensed Consolidated Financial Statements, see "Critical Accounting Policies and Estimates" in our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no significant changes to our policies during the nine months ended September 30, 2026 from those previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025.

During the nine months ended September 30, 2026, our accounting for equity-linked instruments, specifically warrants, became a critical accounting estimate due to the significance of these instruments and the related changes in fair value, together with the use of significant unobservable inputs in their valuation.

Fair Value of Warrants

We evaluate the terms of warrants and similar equity-linked instruments to determine whether the instruments should be classified as liabilities or equity. This evaluation requires judgment and is based on the specific contractual terms of each warrant and the applicable accounting guidance. Warrants classified as liabilities are initially recorded at fair value and remeasured at fair value at each reporting date, with changes in fair value recognized in earnings. Warrants classified as equity are initially recorded at fair value and are not subsequently remeasured.

Fair value measurements of warrants may be categorized within Level 3 of the fair value hierarchy when the valuation incorporates significant unobservable inputs, principally expected stock-price volatility. We estimate the fair value of these warrants using the Black-Scholes model, when appropriate, which incorporates assumptions including the Company's stock price, the exercise price of the warrant, the remaining contractual term, expected stock-price volatility and the risk-free interest rate. The selection of an appropriate valuation methodology and assumptions requires judgment and may differ depending on the terms and characteristics of the applicable warrant.

43

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Our exposure to market risks has not changed materially from those disclosed under "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the year ended December 31, 2025.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) adopted by the SEC under the Exchange Act).

Based on this evaluation and because of the previously-reported material weaknesses in internal control over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, 2026.

Notwithstanding the conclusion by our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures as of September 30, 2026 were not effective, our management, including our Chief Executive Officer and Chief Financial Officer, has concluded that the Condensed Consolidated Financial Statements as of and for the three and nine months ended September 30, 2026 and 2025 present fairly, in all material respects, our financial position, results of operations and cash flows in conformity with GAAP.

Remediation Plan and Status

As of September 30, 2026, the material weaknesses previously disclosed have not yet been remediated. In response to the material weaknesses in our internal control over financial reporting, management has initiated remediation efforts, which includes:

•hired and are continuing to hire professionals with the appropriate skills to perform control activities;

•continuing to augment our internal resources by employing several consultants with deep experience in key areas and we plan to continue to utilize these resources until we add personnel to our staff mentioned above;

•developing and providing incremental training to the accounting and financial reporting team;

•designing and implementing additional and/or enhanced controls in the areas of account reconciliations, contract accounting, financial statement analysis prepared in conformity with GAAP and manual journal entries;

•enhancing controls over segregation of duties;

•with the guidance and participation of our internal audit function, we have a monitoring program to:

•evaluate and assess whether controls are present and functioning in a timely manner; and,

•hold individuals accountable for their internal control responsibilities.

We will continue to work toward full remediation of the material weaknesses to improve our internal control over financial reporting. The material weaknesses will not be considered remediated until the new and redesigned controls operate for a sufficient period of time and management has concluded, through testing, that these controls are designed and operating effectively. Accordingly, we will continue to monitor and evaluate the effectiveness of our internal control over financial reporting in the areas affected by the material weaknesses.

Changes in Internal Control Over Financial Reporting

There were no changes in internal control over financial reporting (as defined by Rule 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations in Effectiveness of Controls

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures, or our internal controls, will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are

44

met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple error, mistake or fraud. Additionally, controls can be circumvented by individuals or groups of persons or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements in our public reports due to error or fraud may occur and not be detected.

PART II

Item 1. Legal Proceedings

Refer to our Annual Report on Form 10-K for the year ended December 31, 2025 as there have been no material changes and no new litigation to disclose as of September 30, 2026.

Item 1A. Risk Factors

We are subject to various risks and uncertainties in the course of our business. The discussion of such risks and uncertainties may be found under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025. Other than as described below, there have been no material changes to the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2025.

A nationwide shortage of skilled labor, particularly boilermakers and other construction trades, has increased and may continue to increase our costs, reduce productivity and adversely affect our ability to execute projects and our operating results.

Our construction, depends on a availability of skilled craft labor, including boilermakers, welders, pipe fitters and other skilled trades. An increase in power demand, including from data centers, industrial growth and the electrification of the economy, has led to more construction of new generation capacity resulting in a nationwide shortfall of skilled labor. These labor constraints can increase our construction costs and affect productivity on certain projects.

We may not be able to pass increased labor costs on to customers or recover them through escalation clauses, change orders or claims.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

There were no sales of unregistered equity securities during the quarter ended September 30, 2026.

Issuer Purchases of Equity Securities

The following table details our common stock repurchases during the three months ended September 30, 2026:

(in thousands, except per share amounts)
Period						Total Number of Shares Purchased						Average Price Paid per Share						Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs						Approximate Dollar Value of Shares That May Yet be Purchased Under the Plans or Programs (1)
July 1 - July 31, 2026						—						$	—					—						$	—
August 1 - August 31, 2026 (2)						3,663						9.93						3,663						13,634
September 1 - September 30, 2026						200						7.39						200						12,156
Total						3,863						$	9.80					3,863						$	12,156

(1) On July 13, 2026, we announced a share repurchase program of up to $50 million of our outstanding common stock as authorized by our Board of Directors. Under the program, we may repurchase shares from time to time in open-market transactions, in privately negotiated transactions, through

45

block trades or pursuant to trading plans established in accordance with Rule 10b5-1 or Rule 10b-18 under the Exchange Act based on market conditions, share price and other factors. The program does not obligate us to purchase any shares, has no fixed expiration date and may be suspended or discontinued at any time.

(2) On August 18, 2026, we purchased 1.3 million shares of our common stock from the Company's pension trust for $12.7 million. See Note 20 to the Condensed Consolidated Financial Statements for further information.

Item 5. Other Information

During the three months ended September 30, 2026, none of our directors or officers adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

Item 6. Exhibits

2.1*						Master Separation Agreement, dated as of June 8, 2015, between The Babcock & Wilcox Company and Babcock & Wilcox Enterprises, Inc. (incorporated by reference to Exhibit 2.1 to the Babcock & Wilcox Enterprises, Inc. Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 (File No. 001-36876)).
3.1						Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 (File No. 001-36876)).
3.2						Certificate of Amendment of the Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on June 17, 2019 (File No. 001-36876)).
3.3						Certificate of Amendment of the Restated Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on July 24, 2019 (File No. 001-36876)).
3.4						Certificate of Amendment of Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on May 23, 2023 (File No. 001-36876)).
3.5						Amended and Restated Bylaws of Babcock & Wilcox Enterprises, Inc. (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on March 5, 2025 (File No. 001-36876)).
3.6						Certificate of Designations with respect to the 7.75% Series A Cumulative Perpetual Preferred Stock, dated May 6, 2021, filed with the Secretary of State of Delaware and effective on May 6, 2021 (incorporated by reference to Exhibit 3.4 to the Babcock & Wilcox Enterprises, Inc. Form 8-A filed on May 7, 2021 (File No. 001-36876)).
3.7						Certificate of Increase in Number of Shares of 7.75% Series A Cumulative Perpetual Preferred Stock, dated June 1, 2021 (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on July 7, 2021 (File No. 001-36876)).
10.1						Eleventh Amendment to the Credit Agreement among Babcock & Wilcox Enterprises, Inc., the lenders and Axos Bank, dated August 11, 2026, filed herewith (File No. 001-36876).
31.1						Rule 13a-14(a)/15d-14(a) certification of Chief Executive Officer.
31.2						Rule 13a-14(a)/15d-14(a) certification of Chief Financial Officer.
32.1						Section 1350 certification of Chief Executive Officer.
32.2						Section 1350 certification of Chief Financial Officer.
101.SCH						XBRL Taxonomy Extension Schema Document.
101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB						XBRL Taxonomy Extension Label Linkbase Document.
101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF						XBRL Taxonomy Extension Definition Linkbase Document.
104						Cover Page Interactive Data File (embedded within the inline XBRL document)

*As permitted by Regulation S-K, Item 601(b)(2)(ii), certain confidential portions of this exhibit have been redacted from the publicly filed document.

46

47

SIGNATURES

Pursuant to the requirements of the Section 13 or 15(d) of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

						BABCOCK & WILCOX ENTERPRISES, INC.
November 9, 2026			By:			/s/ Cameron Frymyer
						Cameron Frymyer
						Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer and Duly Authorized Representative)

48